var title_f2_6_2144="Fibrous pleural tumor I CT";
var content_f2_6_2144=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63307&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63307&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fibrous tumor of the pleura",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT shows a large posterior thoracic mass enhancing inhomogeneously after intravenous contrast material. The cardiomediastinal structures, including the descending aorta, are shifted to the right, and the left hilus is displaced anteriorly, indicating that this mass is intrapleural rather than intraparenchymal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2144=[""].join("\n");
var outline_f2_6_2144=null;
var title_f2_6_2145="Brain MRI age 4 years juvenile Alexander disease";
var content_f2_6_2145=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F51725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F51725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Early brain MRIs in a patient with presumed juvenile Alexander disease, obtained at the age of four years",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 226px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Extensive cerebral white matter abnormalities are seen on these T2-weighted images (B), with sparing of the occipital U  fibers (arrows, B). The signal abnormality is more pronounced in the frontal than in the occipital white matter. There is an irregular  periventricular rim of low signal intensity (arrowheads, B). The basal ganglia and thalamus have a mildly increased signal intensity.  Within the posterior fossa, signal abnormalities are seen in the central part of the medulla, the hilus of the dentate nucleus, and the  cerebellar hemispheric white matter, characteristically with the normal dentate nucleus prominently visible in between (A).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: van der Knaap, MS, Naidu, S, Breiter, SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22:541. Copyright &copy;2001 American Society of Neuroradiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2145=[""].join("\n");
var outline_f2_6_2145=null;
var title_f2_6_2146="Patient information: Congenital hernia of the diaphragm (The Basics)";
var content_f2_6_2146=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/82810\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/44/27331\">",
"         Congenital hernia of the diaphragm",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?33/16/34050\">",
"         Patient information: Going home from the hospital (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Congenital hernia of the diaphragm (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/congenital-hernia-of-the-diaphragm-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H12979096\">",
"      <span class=\"h1\">",
"       What is a congenital hernia of the diaphragm?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A congenital hernia of the diaphragm is a condition that happens when a baby is growing in the mother&rsquo;s uterus (womb).",
"     </p>",
"     <p>",
"      This condition affects the diaphragm, the layer of muscle that separates the organs in the chest from the organs in the belly. Babies with a congenital hernia of the diaphragm have a hole in their diaphragm. Because of this, some of the organs from the belly can move through this hole into the chest (",
"      <a class=\"graphic graphic_figure graphicRef82792 \" href=\"UTD.htm?26/44/27331\">",
"       figure 1",
"      </a>",
"      ). In the chest, these organs can press on the lungs and keep them from growing normally.",
"     </p>",
"     <p>",
"      A congenital hernia of the diaphragm can be mild or severe. A severe congenital hernia of the diaphragm is life-threatening.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12979111\">",
"      <span class=\"h1\">",
"       What are the symptoms of a congenital hernia of the diaphragm?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Before birth, a congenital hernia of the diaphragm causes no symptoms. The doctor might find out your baby has it when he or she does a routine test, called an ultrasound, to check on your baby during pregnancy. An ultrasound is an imaging test that creates pictures of your baby inside the uterus.",
"     </p>",
"     <p>",
"      After birth, the most common symptom that a baby might have is trouble breathing. This usually starts within a few hours after birth. Some babies have mild trouble breathing, but most babies have severe trouble breathing.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12979126\">",
"      <span class=\"h1\">",
"       Is there a test for a congenital hernia of the diaphragm?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor can do a chest X-ray to check if your baby has this condition.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12979141\">",
"      <span class=\"h1\">",
"       How is a congenital hernia of the diaphragm treated during pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;During pregnancy, your doctor will monitor your baby&rsquo;s health with regular tests. But there is no treatment for this condition during pregnancy.",
"     </p>",
"     <p>",
"      As your due date nears, your doctor will probably talk with you about giving you medicines to help start your labor. Doctors call this &ldquo;inducing labor.&rdquo; Doctors usually induce labor when a baby has a congenital hernia of the diaphragm. That way, the doctors who take care of your baby can be ready to start treatment right after birth.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12979156\">",
"      <span class=\"h1\">",
"       How is a congenital hernia of the diaphragm treated after birth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on your baby&rsquo;s symptoms and how severe the condition is. It usually involves different steps.",
"     </p>",
"     <p>",
"      First, the doctor will treat your baby&rsquo;s breathing and other lung problems. Treatments usually include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A breathing tube &ndash; A breathing tube is a tube that goes down the throat and into the lungs. The other end is attached to a machine that helps with breathing.",
"       </li>",
"       <li>",
"        A nasogastric tube &ndash; This is a thin tube that goes in the nose and down into the stomach. The tube sucks up extra fluid and air in the stomach.",
"       </li>",
"       <li>",
"        An IV &ndash; This is a thin tube that goes into a vein.",
"       </li>",
"       <li>",
"        An umbilical line &ndash; This is a thin tube that goes into a blood vessel in the umbilical cord.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If the breathing tube doesn&rsquo;t help enough, your baby might need to be put on a heart and lung machine. This machine, which doctors call &ldquo;ECMO,&rdquo; takes over the jobs of the heart and lungs. It pumps blood from your baby&rsquo;s body, gives it oxygen, and pumps it back into the body.",
"     </p>",
"     <p>",
"      After your baby&rsquo;s breathing and other lung problems are under control, he or she will need surgery. Surgery is usually done a few days after birth, but the timing depends on your baby&rsquo;s individual situation. During surgery, the doctor will put the belly organs back in the belly and close the hole in the diaphragm.",
"     </p>",
"     <p>",
"      After surgery, babies usually need a breathing tube or to be on a heart and lung machine while they heal.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12979171\">",
"      <span class=\"h1\">",
"       Does a congenital hernia of the diaphragm cause long-term problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. It will depend on your baby&rsquo;s individual situation. But many babies with a congenital hernia of the diaphragm will have long-term problems. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Breathing or other lung problems",
"       </li>",
"       <li>",
"        Not gaining weight or growing normally",
"       </li>",
"       <li>",
"        Digestive problems",
"       </li>",
"       <li>",
"        Learning problems or hearing loss",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12979186\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/16/34050?source=see_link\">",
"       Patient information: Going home from the hospital (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?2/6/2146?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82810 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-7727F3B860-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2146=[""].join("\n");
var outline_f2_6_2146=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12979096\">",
"      What is a congenital hernia of the diaphragm?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12979111\">",
"      What are the symptoms of a congenital hernia of the diaphragm?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12979126\">",
"      Is there a test for a congenital hernia of the diaphragm?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12979141\">",
"      How is a congenital hernia of the diaphragm treated during pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12979156\">",
"      How is a congenital hernia of the diaphragm treated after birth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12979171\">",
"      Does a congenital hernia of the diaphragm cause long-term problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12979186\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/82810\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/44/27331\">",
"      Congenital hernia of the diaphragm",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/16/34050?source=related_link\">",
"      Patient information: Going home from the hospital (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_6_2147="Patient information: Primary hyperparathyroidism (The Basics)";
var content_f2_6_2147=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16549\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/43/15024\">",
"         Thyroid and parathyroid glands",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"UTD.htm?28/58/29611\">",
"          Foods and drinks with calcium",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?36/37/37468\">",
"           Elemental calcium content per pill of different calcium supplements",
"          </a>",
"          <li>",
"           <a class=\"graphic graphic_table\" href=\"UTD.htm?7/12/7372\">",
"            Selected food sources of vitamin D",
"           </a>",
"          </li>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?23/6/23650\">",
"         Patient information: Bone density testing (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/12/36034\">",
"         Patient information: Calcium and vitamin D for bone health (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/56/43905\">",
"         Patient information: Kidney stones in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/58/35746\">",
"         Patient information: Osteoporosis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/29/1491\">",
"         Patient information: Bone density testing (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/60/23491\">",
"         Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/49/25366\">",
"         Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/52/29507\">",
"         Patient information: Primary hyperparathyroidism (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Primary hyperparathyroidism (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/primary-hyperparathyroidism-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H25992201\">",
"      <span class=\"h1\">",
"       What is hyperparathyroidism?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Hyperparathyroidism is a disorder of the parathyroid glands in your neck (",
"      <a class=\"graphic graphic_figure graphicRef66834 \" href=\"UTD.htm?14/43/15024\">",
"       figure 1",
"      </a>",
"      ). These glands make a hormone that helps control the amount of calcium in the blood. This hormone is called &ldquo;parathyroid hormone,&rdquo; or &ldquo;PTH.&rdquo;",
"     </p>",
"     <p>",
"      Hyperparathyroidism is when your parathyroid glands make too much PTH. This causes too much calcium to build up in your blood. Primary hyperparathyroidism, the most common form of hyperparathyroidism, can happen when one or more of the glands get bigger than they should, or when a gland develops an abnormal growth. Cancer is another possible cause of hyperparathyroidism, but this is very rare.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25992216\">",
"      <span class=\"h1\">",
"       What are the symptoms of hyperparathyroidism?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people with this condition have no symptoms. But some people do have symptoms that might be related to having more calcium in their blood than normal. These symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain in the joints",
"       </li>",
"       <li>",
"        Feeling tired or weak",
"       </li>",
"       <li>",
"        Loss of appetite",
"       </li>",
"       <li>",
"        Feeling depressed",
"       </li>",
"       <li>",
"        Trouble concentrating",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If your PTH and blood calcium levels get very high, you might get constipated, feel very thirsty, or urinate more often than usual. Some people have more serious symptoms, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Problems with how the kidneys work",
"       </li>",
"       <li>",
"        Kidney stones",
"       </li>",
"       <li>",
"        Weak bones",
"       </li>",
"       <li>",
"        Gout (a kind of arthritis) or other problems in the joints",
"       </li>",
"       <li>",
"        Chemical imbalances in the blood",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      &ldquo;Parathyroid crisis&rdquo; is a rare but serious problem. It can happen if you have hyperparathyroidism and get sick with something that causes you to lose fluids (like vomiting or diarrhea). This causes the amounts of PTH and calcium in the blood to go up suddenly. If this happens, you might have belly pain, nausea, and sometimes problems thinking clearly and staying alert. It is important to see a doctor or nurse right away if you have hyperparathyroidism plus lasting vomiting or diarrhea, and can't keep fluids down.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25992231\">",
"      <span class=\"h1\">",
"       Is there a test for hyperparathyroidism?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. A doctor or nurse can tell if you have hyperparathyroidism by measuring the levels of PTH and calcium in your blood. Many people with hyperparathyroidism do not notice any symptoms. The condition is often found when a doctor or nurse does a blood test for some other reason.",
"     </p>",
"     <p>",
"      If you have hyperparathyroidism, your doctor or nurse might do other tests, too. You will probably get a special kind of X-ray to see if your bones are weaker than normal. Plus, you might get checked for kidney stones, if you have had kidney stones in the past.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25992246\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to help my condition?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Even if you do not have any symptoms, there are things you can do to help prevent problems:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Drink plenty of liquids, and try not to get dehydrated. This can help to prevent kidney stones.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Stay active. This can help keep your calcium levels normal and your bones healthy.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Try to get about 1000 milligrams of calcium each day. These tables show how much calcium is in certain foods and vitamin supplements (",
"        <a class=\"graphic graphic_table graphicRef67824 \" href=\"UTD.htm?28/58/29611\">",
"         table 1",
"        </a>",
"        and",
"        <a class=\"graphic graphic_table graphicRef70454 \" href=\"UTD.htm?36/37/37468\">",
"         table 2",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Try to get about 400 to 600 international units (IU) of vitamin D each day (",
"        <a class=\"graphic graphic_table graphicRef77982 \" href=\"UTD.htm?7/12/7372\">",
"         table 3",
"        </a>",
"        ). Not having enough vitamin D can weaken your bones.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Do not take certain medicines that can affect the amount of calcium in the blood. Your doctor or nurse can tell you which medicines to avoid.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Even if you feel healthy, your doctor or nurse should still check your blood calcium every 6 months. He or she will also do regular tests to check your kidneys and bones. (People whose bones are weakened because of their condition can get medicines to help protect their bones.)",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25992261\">",
"      <span class=\"h1\">",
"       How is hyperparathyroidism treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main treatment is surgery to remove the gland or glands that are causing the problem. (In most cases, surgery cures the hyperparathyroidism.) Still, people who have no symptoms do not always need surgery.",
"     </p>",
"     <p>",
"      You will most likely need surgery if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        The amount of calcium in your blood is much higher than normal;",
"       </li>",
"       <li>",
"        Your hyperparathyroidism is causing problems with your kidneys or bones;",
"       </li>",
"       <li>",
"        You are younger than 50; or",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        You are not able to get regular checkups and tests.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25992276\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=see_link\">",
"       Patient information: Osteoporosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/6/23650?source=see_link\">",
"       Patient information: Bone density testing (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/56/43905?source=see_link\">",
"       Patient information: Kidney stones in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/52/29507?source=see_link\">",
"       Patient information: Primary hyperparathyroidism (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=see_link\">",
"       Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=see_link\">",
"       Patient information: Bone density testing (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/56/43905?source=see_link\">",
"       Patient information: Kidney stones in adults (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?2/6/2147?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16549 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-A0D016103C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2147=[""].join("\n");
var outline_f2_6_2147=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25992201\">",
"      What is hyperparathyroidism?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25992216\">",
"      What are the symptoms of hyperparathyroidism?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25992231\">",
"      Is there a test for hyperparathyroidism?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25992246\">",
"      Is there anything I can do on my own to help my condition?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25992261\">",
"      How is hyperparathyroidism treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25992276\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16549\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/43/15024\">",
"      Thyroid and parathyroid glands",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"UTD.htm?28/58/29611\">",
"       Foods and drinks with calcium",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_table\" href=\"UTD.htm?36/37/37468\">",
"        Elemental calcium content per pill of different calcium supplements",
"       </a>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?7/12/7372\">",
"         Selected food sources of vitamin D",
"        </a>",
"       </li>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=related_link\">",
"      Patient information: Bone density testing (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/6/23650?source=related_link\">",
"      Patient information: Bone density testing (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/56/43905?source=related_link\">",
"      Patient information: Kidney stones in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=related_link\">",
"      Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/52/29507?source=related_link\">",
"      Patient information: Primary hyperparathyroidism (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_6_2148="Stye PI";
var content_f2_6_2148=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F81682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F81682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stye",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This person has a stye in the middle of the lower eyelid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2148=[""].join("\n");
var outline_f2_6_2148=null;
var title_f2_6_2149="Overview of metacarpal fractures";
var content_f2_6_2149=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of metacarpal fractures",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/6/2149/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/6/2149/contributors\">",
"     Josh Bloom, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/6/2149/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/6/2149/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/6/2149/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/6/2149/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/6/2149/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metacarpal fractures account for 30 to 40 percent of all hand fractures. These fractures are usually the result of direct trauma, but fatigue fractures can occur in athletes or as occupational injuries due to repetitive stress. The biomechanics, diagnosis, and treatment of stress fractures are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23866?source=see_link\">",
"     \"Overview of stress fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Splinting is used in the initial immobilization of, and often is the definitive treatment for, metacarpal fractures. A detailed description of the techniques for applying splints is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=see_link\">",
"     \"Splinting of musculoskeletal injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will provide an overview of the classification and examination of metacarpal fractures as well as the anatomy of the metacarpal bones.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metacarpal fractures are classified based upon their anatomic location. Fractures of the second, third, fourth, and fifth metacarpals are subdivided into those affecting the metacarpal head, neck, shaft, or base. Due to the unique biomechanics and anatomy of the thumb, fractures of the first metacarpal are classified separately.",
"   </p>",
"   <p>",
"    Metacarpal fractures are further described by the degree of displacement, angulation, shortening, rotation, and by the fracture type (transverse, oblique, spiral, comminuted, impacted, or avulsion). The metacarpal neck and shaft are the most common sites for second through fifth metacarpal fractures, while the first metacarpal is usually fractured at the base.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Locations of fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to the different locations of metacarpal fractures are discussed separately in the appropriate topic reviews:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fracture of the head of metacarpal (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51598 \" href=\"UTD.htm?13/31/13823\">",
"       image 1",
"      </a>",
"      ), other than that of the thumb (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22707?source=see_link\">",
"       \"Metacarpal head fractures\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fracture of the neck of a metacarpal (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef66007 \" href=\"UTD.htm?10/54/11119\">",
"       image 2",
"      </a>",
"      ), other than that of the thumb (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13382?source=see_link\">",
"       \"Metacarpal neck fractures\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fracture of the shaft of a metacarpal (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76416 \" href=\"UTD.htm?6/43/6847\">",
"       image 3",
"      </a>",
"      ), other than that of the thumb (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20565?source=see_link\">",
"       \"Metacarpal shaft fractures\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fracture of the base of a metacarpal (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58725 \" href=\"UTD.htm?4/19/4415\">",
"       image 4",
"      </a>",
"      ), other than that of the thumb (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/9/22675?source=see_link\">",
"       \"Metacarpal base fractures\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fractures of the first metacarpal (thumb) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72289 \" href=\"UTD.htm?17/30/17888\">",
"       image 5",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17828?source=see_link\">",
"       \"First (thumb) metacarpal fractures\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The metacarpals are cortical bones with a concave volar (palmar) surface that is typically 20 percent thicker than the dorsal surface. Proximally, they articulate with the distal carpal row at the carpometacarpal (CMC) joints and with each other at the intermetacarpal joints. Distally, the metacarpals join the proximal phalanx of each finger at the metacarpophalangeal (MCP) joint.",
"   </p>",
"   <p>",
"    The metacarpals are the key skeletal elements forming the two transverse arches of the hand (at the CMC joint, and the metacarpal heads) and the longitudinal arch through its dorsally convex surface. The metacarpals are bound proximally by the palmar metacarpal ligaments and distally by the deep transverse metacarpal ligaments. Collateral ligaments of the MCP joints also provide some degree of stability distally.",
"   </p>",
"   <p>",
"    The \"cam\" shape of the metacarpal head changes the support afforded by the collateral ligaments based upon the degree of flexion occurring at the MCP joint. The ligaments relax in extension (allowing lateral motion of the digit), but are taut in flexion (",
"    <a class=\"graphic graphic_figure graphicRef65855 \" href=\"UTD.htm?0/25/415\">",
"     figure 1",
"    </a>",
"    ). An understanding of this anatomic principle is important because of its effect on the approach to splinting. A basic tenet of hand splinting calls for maintenance of the MCP joint in flexion to avoid immobility contractures of the collateral ligaments.",
"   </p>",
"   <p>",
"    The dorsal and volar interosseous muscles originate from the metacarpal shafts and insert onto the proximal phalanges, thereby functioning as flexors of the MCP joint. In metacarpal neck and shaft fractures, the force exerted by these interosseous muscles tends to cause apex dorsal angulation of the fracture. The common palmar digital arteries and nerves run parallel with the distal portion of each metacarpal. They are rarely injured except in significantly displaced metacarpal head or neck fractures.",
"   </p>",
"   <p>",
"    The second and third metacarpals are essentially fixed at the CMC joints, providing an anchor for the ligamentous, bony, and muscular attachments of the hand. The fourth and fifth metacarpals have progressively more mobility at the CMC joint. This increased mobility is important for a cupping action of the hand. The thumb is the most mobile of the metacarpals, enabling a unique ability to function in opposition as a pincer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial examination includes an assessment of the presence or absence of gross deformity, skin integrity, neurovascular integrity, and malrotation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Deformity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The injured metacarpal is examined for shortening and dorsal angulation. Hyperextension of the MCP joint with flexion of the proximal interphalangeal (PIP) joint at rest or with attempted extension of the finger is referred to as \"pseudo-clawing\".",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Skin integrity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The skin is inspected for evidence of one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lacerations",
"     </li>",
"     <li>",
"      Puncture wounds, particularly those suggesting bites or with evidence of secondary infection",
"     </li>",
"     <li>",
"      Protrusion of bone fragments indicative of a compound fracture",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lacerations or puncture wounds require copious irrigation. If the injuries are suspected to extend deep to the skin, further evaluation is necessary to determine whether tendons have been disrupted or the joint capsule penetrated. If there are injuries to these structures, surgical consultation is appropriate. Open management rather than primary closure of the skin wounds is appropriate for lacerations or puncture wounds of the skin that are due to human bites or to bone fragments in the case of a compound fracture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31013?source=see_link\">",
"     \"Soft tissue infections due to human bites\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If medicolegal considerations warrant, photographs of the injury may be taken with the patient's permission. If there are signs of soft tissue infection, wound and blood cultures should be obtained prior to initiating antibiotic therapy. Broad spectrum antibiotic coverage is necessary for established hand infection due to human oral flora. Although the use of prophylactic antibiotics is of unproven benefit for human bites overall, broad spectrum antibiotics appear to be beneficial with hand bites. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31013?source=see_link\">",
"     \"Soft tissue infections due to human bites\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neurovascular integrity",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted earlier, damage to the neurovascular structures is unusual in metacarpal fractures unless there is substantial displacement or the fracture is in proximity to the motor branch of the ulnar nerve as it courses near the base of the fourth and fifth metacarpals. It is appropriate to test skin sensation, intrinsic muscle function (abduction and adduction of the fingers), and capillary refill to determine the integrity of the nerves and arterial supply to the affected fingers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Assessment for malrotation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rotational alignment of the metacarpals can be assessed in two ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With a semi-clenched fist (flexion to 90 degrees at the MCP and PIP joints), normal alignment will show convergence of the digits, but not necessarily to a single point (",
"      <a class=\"graphic graphic_picture graphicRef73269 graphicRef71612 \" href=\"UTD.htm?4/2/4134\">",
"       picture 1A-B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Have the patient flex the MCP joint 90 degrees with the PIP and distal interphalangeal (DIP) joints in full extension. The plane of the fingernails should be aligned, and can be compared with the contralateral side (",
"      <a class=\"graphic graphic_picture graphicRef52326 \" href=\"UTD.htm?14/14/14575\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even a few degrees of malrotation will cause clinically significant malalignment and functional deficits. Referral for reduction is necessary if any malrotation is noted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general principals of fracture management apply to metacarpal fractures. The following are recommended, but the approach to specific metacarpal fractures is presented separately on the appropriate topic reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2149/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/58/17318?source=see_link\">",
"     \"General principles of acute fracture management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Minimize further tissue injury, particularly of neural and vascular structures by immobilizing the fracture. Because substantial soft tissue swelling can occur, initial immobilization is generally achieved by applying a removable plaster or fiberglass splint. For nondisplaced, well aligned, extraarticular fractures, the splint may serve as definitive treatment. In other cases the splint will later be removed to allow reduction, fixation, or will need to be replaced with a better fitting splint or short arm cast.",
"     </li>",
"     <li>",
"      Icing is used to minimize swelling.",
"     </li>",
"     <li>",
"      Analgesics",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most patients get adequate pain relief from immobilization of their hand, ice, and over-the-counter analgesics such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    . Opioid analgesics are occasionally needed to control pain during the first three to five days. Patients requesting opiates beyond this time should be reevaluated for irritation from a poorly fitting splint, a missed secondary injury, or a fracture complication.",
"   </p>",
"   <p>",
"    Patients with displaced metacarpal fractures awaiting urgent surgical intervention should be managed with splinting, ice, and nonopioid analgesics, if possible, to avoid cognitive impairment prior to consenting to surgery.",
"   </p>",
"   <p>",
"    Further management of metacarpal fractures varies with the anatomic location of the fracture (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Locations of fractures'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30243?source=see_link\">",
"       \"Patient information: Fractures (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=see_link\">",
"       \"Patient information: Cast and splint care (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"       \"Patient information: Cast and splint care (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48141897\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Metacarpal fractures account for 30 to 40 percent of all hand fractures. These fractures are usually the result of direct trauma.",
"     </li>",
"     <li>",
"      Metacarpal fractures are classified based upon their anatomic location. Fractures of the second, third, fourth, and fifth metacarpals are subdivided into those affecting the head, neck, shaft, or base. Due to the unique biomechanics and anatomy of the thumb, fractures of the first (thumb) metacarpal are classified differently. Each of these fracture types is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20565?source=see_link\">",
"       \"Metacarpal shaft fractures\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/9/22675?source=see_link\">",
"       \"Metacarpal base fractures\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13382?source=see_link\">",
"       \"Metacarpal neck fractures\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22707?source=see_link\">",
"       \"Metacarpal head fractures\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17828?source=see_link\">",
"       \"First (thumb) metacarpal fractures\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H4\">",
"       'Anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial examination of a potential metacarpal injury includes an assessment of the presence or absence of gross deformity, skin integrity, neurovascular integrity, and malrotation. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial management of metacarpal fractures consists of immobilization, to reduce pain and minimize further injury, icing, to minimize swelling, and analgesia. Over-the-counter analgesic medications are typically sufficient. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13141801\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and editors would like to acknowledge Kevin E Burroughs, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2149/abstract/1\">",
"      Statius Muller MG, Poolman RW, van Hoogstraten MJ, Steller EP. Immediate mobilization gives good results in boxer's fractures with volar angulation up to 70 degrees: a prospective randomized trial comparing immediate mobilization with cast immobilization. Arch Orthop Trauma Surg 2003; 123:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2149/abstract/2\">",
"      Braakman M, Oderwald EE, Haentjens MH. Functional taping of fractures of the 5th metacarpal results in a quicker recovery. Injury 1998; 29:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2149/abstract/3\">",
"      Harding IJ, Parry D, Barrington RL. The use of a moulded metacarpal brace versus neighbour strapping for fractures of the little finger metacarpal neck. J Hand Surg Br 2001; 26:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2149/abstract/4\">",
"      Kuokkanen HO, Mulari-Ker&auml;nen SK, Niskanen RO, et al. Treatment of subcapital fractures of the fifth metacarpal bone: a prospective randomised comparison between functional treatment and reposition and splinting. Scand J Plast Reconstr Surg Hand Surg 1999; 33:315.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 256 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-65E6C3AFCD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2149=[""].join("\n");
var outline_f2_6_2149=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H48141897\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Locations of fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Deformity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Skin integrity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neurovascular integrity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Assessment for malrotation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H48141897\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13141801\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/256\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/256|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/31/13823\" title=\"diagnostic image 1\">",
"      Comminuted metacarpal head fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/54/11119\" title=\"diagnostic image 2\">",
"      Metacarpal neck fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/43/6847\" title=\"diagnostic image 3\">",
"      Transverse metacarpal shaft fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/19/4415\" title=\"diagnostic image 4\">",
"      Metacarpal base fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/30/17888\" title=\"diagnostic image 5\">",
"      Fracture of thumb metacarpal base Bennetts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/256|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/25/415\" title=\"figure 1\">",
"      MCP collateral ligaments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/256|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/37/40528\" title=\"picture 1A\">",
"      Examination metacarpal malrotation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/20/39232\" title=\"picture 1B\">",
"      Metacarpal fracture with malrotation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/14/14575\" title=\"picture 2\">",
"      Examination metacarpal malrotation 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17828?source=related_link\">",
"      First (thumb) metacarpal fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/58/17318?source=related_link\">",
"      General principles of acute fracture management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/9/22675?source=related_link\">",
"      Metacarpal base fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22707?source=related_link\">",
"      Metacarpal head fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13382?source=related_link\">",
"      Metacarpal neck fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20565?source=related_link\">",
"      Metacarpal shaft fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23866?source=related_link\">",
"      Overview of stress fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=related_link\">",
"      Patient information: Cast and splint care (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=related_link\">",
"      Patient information: Cast and splint care (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30243?source=related_link\">",
"      Patient information: Fractures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31013?source=related_link\">",
"      Soft tissue infections due to human bites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_6_2150="Cross section of the eye";
var content_f2_6_2150=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F59910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F59910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Horizontal section of the eyeball",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 532px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Representation of a horizontal section of the eyeball reveals its three coats: (1) external or fibrous coat (sclera and cornea); (2) middle or vascular coat (choroid, ciliary body, and iris); and (3) internal or retinal layer. The four refractive media are the cornea, the aqueous humor in the anterior chamber, the lens, and the vitreous body.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2150=[""].join("\n");
var outline_f2_6_2150=null;
var title_f2_6_2151="Rho(D) immune globulin (intramuscular): Pediatric drug information";
var content_f2_6_2151=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Rho(D) immune globulin (intramuscular): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?10/58/11175?source=see_link\">",
"    see \"Rho(D) immune globulin (intramuscular): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?8/38/8804?source=see_link\">",
"    see \"Rho(D) immune globulin (intramuscular): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F9838303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F217876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      HyperRHO&trade; S/D Full Dose;",
"     </li>",
"     <li>",
"      HyperRHO&trade; S/D Mini-Dose;",
"     </li>",
"     <li>",
"      MICRhoGAM&reg; UF Plus;",
"     </li>",
"     <li>",
"      RhoGAM&reg; UF Plus;",
"     </li>",
"     <li>",
"      Rhophylac&reg;;",
"     </li>",
"     <li>",
"      WinRho&reg; SDF",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F217877\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      WinRho&reg; SDF",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1061830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Immune Globulin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1061824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/58/11175?source=see_link\">",
"      see \"Rho(D) immune globulin (intramuscular): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children:",
"     <b>",
"      ITP:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     WinRho&reg; SDF: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Initial:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Hemoglobin &lt;10 g/dL: 25-40 mcg/kg as single dose or divided into 2 doses given on separate days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Hemoglobin &ge;10 g/dL: 50 mcg/kg as single dose or divided into 2 doses given on separate days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Maintenance:",
"     <b>",
"      Note:",
"     </b>",
"     Usage dependent upon clinical response, platelet count, hemoglobin, red blood cell counts, and reticulocyte levels; platelet counts &gt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     rarely require treatment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Response to initial dose: 25-60 mcg/kg as single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Nonresponse to initial therapy:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Hemoglobin &lt;8 g/dL: Alternative therapy should be used",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Hemoglobin 8-10 g/dL: 25-40 mcg/kg as single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Hemoglobin &gt;10 g/dL: 50-60 mcg/kg as single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Alternative dosing: New onset: 75 mcg/kg as a single dose has been used in pediatric patients with platelets of &le;20,000/&mu;L (Tarantino, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      ITP:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Rhophylac&reg;: I.V.: 50 mcg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     WinRho&reg; SDF: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Initial: 50 mcg/kg as a single injection, or can be given as a divided dose on separate days. If hemoglobin is &lt;10 g/dL: Dose should be reduced to 25-40 mcg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Subsequent dosing: 25-60 mcg/kg can be used if required to increase platelet count",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Maintenance dosing if patient",
"     <b>",
"      did respond",
"     </b>",
"     to initial dosing: 25-60 mcg/kg based on platelet count and hemoglobin concentration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Maintenance dosing if patient",
"     <b>",
"      did not respond",
"     </b>",
"     to initial dosing:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Hemoglobin &lt;8 g/dL: Alternative treatment should be used",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Hemoglobin 8-10 g/dL: Redose between 25-40 mcg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Hemoglobin &gt;10 g/dL: Redose between 50-60 mcg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Rh",
"      <sub>",
"       o",
"      </sub>",
"      (D) suppression:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     One &ldquo;full dose&rdquo; (300 mcg) provides enough antibody to prevent Rh sensitization if the volume of RBC entering the circulation is &le;15 mL. When &gt;15 mL  is suspected, a fetal red cell count should be performed to determine the appropriate dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Pregnancy:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Antepartum prophylaxis: In general, single dose is given at 28 weeks. If given early in pregnancy, administer every 12 weeks to ensure adequate levels of passively acquired anti-Rh.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     HyperRHO&trade; S/D Full Dose, RhoGAM&reg;: I.M.: 300 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Rhophylac&reg;, WinRho&reg; SDF: I.M., I.V.: 300 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Postpartum: In general, dose is administered as soon as possible after delivery, preferably within 72 hours. Can be given up to 28 days following delivery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     HyperRHO&trade; S/D Full Dose, RhoGAM&reg;: I.M.: 300 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Rhophylac&reg;: I.M., I.V.: 300 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     WinRho&reg; SDF: I.M., I.V.: 120 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Threatened abortion, any time during pregnancy (with continuation of pregnancy):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     HyperRHO&trade; S/D Full Dose, RhoGAM&reg;: I.M.: 300 mcg; administer as soon as possible",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Rhophylac&reg;, WinRho&reg; SDF: I.M., I.V.: 300 mcg; administer as soon as possible",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Abortion, miscarriage, termination of ectopic pregnancy:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     RhoGAM&reg;: I.M.: &ge;13 weeks gestation: 300 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     HyperRHO&trade; S/D Mini Dose, MICRhoGAM&reg;: I.M.: &lt;13 weeks gestation: 50 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Rhophylac&reg;: I.M., I.V.: 300 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     WinRho&reg; SDF: I.M., I.V.: After 34 weeks gestation: 120 mcg; administer immediately or within 72 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Amniocentesis, chorionic villus sampling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     HyperRHO&trade; S/D Full Dose, RhoGAM&reg;: I.M.: At 15-18 weeks gestation or during the 3rd trimester: 300 mcg. If dose is given between 13-18 weeks, repeat at 26-28 weeks and within 72 hours of delivery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Rhophylac&reg;: I.M., I.V.: 300 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     WinRho&reg; SDF: I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Before 34 weeks gestation: 300 mcg; administer immediately, repeat dose every 12 weeks during pregnancy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     After 34 weeks gestation: 120 mcg, administered immediately or within 72 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Excessive fetomaternal hemorrhage (&gt;15 mL): Rhophylac&reg;: I.M., I.V.: 300 mcg within 72 hours plus 20 mcg/mL fetal RBCs in excess of 15 mL if excess transplacental bleeding is quantified or 300 mcg/dose if bleeding cannot be quantified",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Abdominal trauma, manipulation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     HyperRHO&trade; S/D Full Dose, RhoGAM&reg;: I.M.: 2nd or 3rd trimester: 300 mcg. If dose is given between 13-18 weeks, repeat at 26-28 weeks and within 72 hours of delivery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Rhophylac&reg;: I.M., I.V.: 300 mcg within 72 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     WinRho&reg; SDF: I.M., I.V.: After 34 weeks gestation: 120 mcg; administer immediately or within 72 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Transfusion:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     HyperRHO&trade; S/D Full Dose, RhoGAM&reg;: I.M.: Multiply the volume of Rh positive whole blood administered by the hematocrit of the donor unit to equal the volume of RBCs transfused. The volume of RBCs is then divided by 15 mL, providing the number of 300 mcg doses (vials/syringes) to administer. If the dose calculated results in a fraction, round up to the next higher whole 300 mcg dose (vial/syringe).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     WinRho&reg; SDF: Administer within 72 hours after exposure of incompatible blood transfusions or massive fetal hemorrhage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.V.: Calculate dose as follows; administer 600 mcg every 8 hours until the total dose is administered:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Exposure to Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) positive whole blood: 9 mcg/mL blood",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Exposure to Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) positive red blood cells: 18 mcg/mL cells",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.M.: Calculate dose as follows; administer 1200 mcg every 12 hours until the total dose is administered:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Exposure to Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) positive whole blood: 12 mcg/mL blood",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Exposure to Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) positive red blood cells: 24 mcg/mL cells",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Rhophylac&reg;: I.M., I.V.: 20 mcg per 2 mL transfused blood or 1 mL erythrocyte concentrate",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F217855\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     HyperRHO&trade; S/D Full Dose: 300 mcg/mL (1 mL) [&ge;1500 units; for I.M. use only]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     HyperRHO&trade; S/D Mini-Dose: 50 mcg/0.17 mL (0.17 mL) [&ge;250 units; for I.M. use only]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     MICRhoGAM&reg; UF Plus: 50 mcg/0.75 mL (0.75 mL) [contains polysorbate 80; 250 units; for I.M. use only; volume is expressed as an approximate value]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     RhoGAM&reg; UF Plus: 300 mcg/0.75 mL (0.75 mL) [contains polysorbate 80; 1500 units; for I.M. use only; volume is expressed as an approximate value]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rhophylac&reg;: 300 mcg/2 mL (2 mL) [contains albumin (human); 1500 units; for I.M. or I.V. use]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     WinRho&reg; SDF: 3000 mcg/~13 mL (13 mL) [contains maltose, polysorbate 80; 15,000 units; for I.M. or I.V. use; volume is expressed as an approximate value]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     WinRho&reg; SDF: 300 mcg/~1.3 mL (1.3 mL) [contains maltose, polysorbate 80; 1500 units; for I.M. or I.V. use; volume is expressed as an approximate value]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     WinRho&reg; SDF: 500 mcg/~2.2 mL (2.2 mL) [contains maltose, polysorbate 80; 2500 units; for I.M. or I.V. use; volume is expressed as an approximate value]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     WinRho&reg; SDF: 1000 mcg/~4.4 mL (4.4 mL) [contains maltose, polysorbate 80; 5000 units; for I.M. or I.V. use; volume is expressed as an approximate value]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F217839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1061833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: WinRho&reg; SDF and Rhophylac&reg; are the only immune globulin products available that can be administered both I.M. and I.V.; however,",
"     <b>",
"      for the treatment of ITP, it must be administered I.V.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Administer into the deltoid muscle of upper arm or the anterolateral aspect of the upper thigh; the gluteal region is not recommended for routine administration due to the potential risk of sciatic nerve injury; if gluteal area is used, administer only in the upper, outer quadrant. The total volume can be given in divided doses at different sites at one time or may be divided and given at intervals provided the total dosage is given within 72 hours of the fetomaternal hemorrhage or transfusion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     WinRho&reg; SDF: Infuse over 3-5 minutes; if further dilution is desired, use NS as diluent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rhophylac&reg;: ITP: Infuse at 2 mL per 15-60 seconds",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1061827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 2&deg;C to 8&deg;C (35&deg;F to 46&deg;F), do not freeze.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RhoGAM&reg; UF Plus, MICRhoGAM&reg; UF Plus: May be stored at 25&deg;C (77&deg;F) for up to 10 days [data on file (Ortho Clinical Diagnostics, 2011)]; however, the manufacturer recommends storage under refrigeration. Room temperature stability information should only be utilized in situations where the drug has been inadvertently exposed to prolonged room temperature.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HyperRHO&trade; S/D may be stored at 25&deg;C (77&deg;F) for ~2 weeks [data on file (Talecris Biotherapeutics, 2011)]; however, the manufacturer recommends storage under refrigeration. Room temperature stability information should only be utilized in situations where the drug has been inadvertently exposed to prolonged room temperature.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rhophylac&reg;: Protect from light.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1061832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suppression of Rh isoimmunization: Use in the following situations when an Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D)-negative individual is exposed to Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D)-positive blood: During delivery of an Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D)-positive infant; abortion; amniocentesis; chorionic villus sampling; ruptured tubal pregnancy; abdominal trauma; transplacental hemorrhage. Used when the mother is Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) negative, the father of the child is either Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) positive or Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) unknown, the baby is either Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) positive or Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) unknown (FDA approved in pregnant women)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Transfusion: Suppression of Rh isoimmunization in Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D)-negative individuals transfused with Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) antigen-positive RBCs or blood components containing Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) antigen-positive RBCs (FDA approved in adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Treatment of idiopathic thrombocytopenic purpura (ITP): Used intravenously in the following nonsplenectomized Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) positive individuals: Acute ITP (WinRho&reg; SDF:  FDA approved in children), chronic ITP (Rhophylac&reg;: FDA approved in adults; WinRho&reg; SDF: FDA approved in children and adults), ITP secondary to HIV infection (WinRho&reg; SDF: FDA approved in children and adults)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F217896\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hyper-/hypotension, pallor, vasodilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, dizziness, fever, headache, malaise, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Haptoglobin decreased, hemoglobin decreased (patients with ITP), intravascular hemolysis (patients with ITP)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Bilirubin increased, LDH increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction: Discomfort, induration, mild pain, redness, swelling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, hyperkinesia, myalgia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Acute renal insufficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, diaphoresis, infusion-related reactions, positive anti-C antibody test (transient), shivering",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Anemia (clinically-compromising), anuria, ARDS, cardiac arrest, cardiac failure, chest pain, chromaturia, DIC, edema, erythema, fatigue, hematuria, hemoglobinemia, hemoglobinuria (transient in patients with ITP), hyperhidrosis, hypersensitivity, injection site irritation, jaundice, myocardial infarction, muscle spasm, nausea, pain in extremities, renal failure, renal impairment, tachycardia, transfusion-related acute lung injury",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1061837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to immune globulin or any component",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Additional product-specific contraindications:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     MICRhoGAM&reg; UF Plus, RhoGAM&reg; UF Plus: Rh-positive patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Rhophylac&reg;: IgA deficiency with antibodies against IgA and history of hypersensitivity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     WinRho&reg; SDF: Autoimmune hemolytic anemia; pre-existing hemolysis or high risk for hemolysis; IgA deficiency with antibodies against IgA and history of hypersensitivity; suppression of isoimmunization in infants",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1061823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Anaphylactic hypersensitivity reactions can occur; use with caution in IgA deficiency; may increase risk of hypersensitivity especially in patients with anti-IgA antibodies present. Use with caution in patients with thrombocytopenia or bleeding disorders; bleeding/hematoma may occur from I.M. administration. Alternative treatment should be used in ITP patients with hemoglobin concentrations &lt;8 g/dL. WinRho&reg; SDF contains maltose; may cause false-positive glucose concentrations.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1061822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     WinRho&reg; SDF and Rhophylac&reg; are the only products approved for treatment of ITP; administer I.V. only when treating ITP. Severe, sometimes fatal, cases of intravascular hemolysis (IVH) have been reported in patients treated for ITP",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; rare but serious signs and symptoms (eg, back pain, shaking chills, fever, and discolored urine) have occurred within 4 hours of administration; IVH has been reported in postmarketing experience in patients treated for ITP and may result in clinically compromising anemia and multiorgan system failure including acute respiratory distress syndrome. Acute renal insufficiency and disseminated intravascular coagulation (DIC) have also been reported. Patients with ITP should be advised of the signs and symptoms of IVH and instructed to report them immediately. Reduce WinRho&reg; SDF dosage in ITP patients with serum Hgb concentration &lt;10 g/dL to minimize the risk of increasing the severity of anemia; consider alternative treatment with hemoglobin &lt;8 g/dL;  monitor for signs and/or symptoms of intravascular hemolysis, clinically compromising anemia, and renal insufficiency.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Product of human plasma; may potentially contain infectious agents which could transmit disease. Screening of donors, as well as testing and/or inactivation or removal of certain viruses, reduces the risk. Infections thought to be transmitted by this product should be reported to the manufacturer. Not intended for use as immunoglobulin replacement therapy for immune deficiency syndromes. When used to suppress Rh isoimmunization, the drug is administered to the mother",
"     <b>",
"      not",
"     </b>",
"     the infant.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Noncardiogenic pulmonary edema has been reported with intravenous immune globulin use. Transfusion-related acute lung injury (TRALI) is characterized by severe respiratory distress, pulmonary edema, hypoxemia, and fever in the presence of normal left ventricular function and usually occurs within 1-6 hours after the infusion. Thrombotic events have been reported with administration of intravenous immune globulins (IVIG); use with caution in patients with a history of atherosclerosis or cardiovascular and/or thrombotic risk factors or patients with known/suspected hyperviscosity. Consider a baseline assessment of blood viscosity in patients at risk for hyperviscosity. Administer at the minimum practical infusion rate.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     MICRhoGAM&reg; UF Plus, RhoGAM&reg; UF Plus, and WinRho&reg; SDF contain polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals. In premature neonates, thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported after receiving parenteral products containing polysorbate 80 (Alade, 1986; CDC, 1984). Infusion of polysorbate 80-containing solutions through polyvinyl chloride tubing may cause DEHP to leach into the solution; in immature animals, exposure to DEHP may adversely affect the development of the male reproductive tract.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F217848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immune Globulins may diminish the therapeutic effect of Vaccines (Live).  Management: Live organism vaccination should be withheld for up to 6 months following immune globulin administration.  Live vaccine given immediately prior to immune globulin may require repeat vaccination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Yellow Fever Vaccine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F217851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F217863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not been conducted. Available evidence suggests that Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) immune globulin administration during pregnancy does not harm the fetus or affect future pregnancies.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1061829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Signs and symptoms of intravascular hemolysis (IVH), anemia, renal insufficiency, back pain, shaking, chills, discolored urine, or hematuria; observe patient for side effects for 8 hours following administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Patients with suspected IVH: CBC, haptoglobin, plasma hemoglobin, urine dipstick, BUN, serum creatinine, liver function tests, DIC-specific tests [D-dimer, fibrin degradation products (FDP) or fibrin split products (FSP)] for differential diagnosis. In patients at increased risk of developing acute renal failure, periodically monitor renal function and urine output. Clinical response may be determined by monitoring platelets, red blood cell (RBC) counts, hemoglobin, and reticulocyte levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ITP: Check blood type, CBC, reticulocyte count, DAT before initiating treatment with WinRho&reg; SDF; check urine dipstick before initiating treatment with WinRho&reg; SDF or Rhophylac&reg; and repeat urine dipstick at 2 and 4 hours after administration and prior to end of the 8-hour monitoring period.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1061821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) antigen is responsible for most cases of Rh sensitization, which occurs when Rh-positive fetal RBCs enter the maternal circulation of an Rh-negative woman. Injection of anti-D globulin results in opsonization of the fetal RBCs, which are then phagocytized in the spleen, preventing immunization of the mother. Injection of anti-D into an Rh-positive patient with ITP coats the patient's own D-positive RBCs with antibody and, as they are cleared by the spleen, they saturate the capacity of the spleen to clear antibody-coated cells, sparing antibody-coated platelets. Other proposed mechanisms involve the generation of cytokines following the interaction between antibody-coated RBCs and macrophages.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1061835\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rh isoimmunization: I.V.: 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ITP: I.V.: 1-2 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: ITP: 7-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ITP (single dose): I.V.: 30 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Passive anti-Rh",
"     <sub>",
"      o",
"     </sub>",
"     (D) antibodies (after 120 mcg dose): I.V.: 6 weeks",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1061836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Appears in breast milk, however, not absorbed by the nursing infant",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 18-30 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 16-24 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 5-10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 2 hours",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F2876784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?8/38/8804?source=see_link\">",
"      see \"Rho(D) immune globulin (intramuscular): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Report symptoms of intravascular hemolysis (eg, back pain, shaking chills, fever, discolored urine, decreased urination, sudden weight gain, fluid retention, and shortness of breath) to your healthcare provider immediately.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1061838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1 mcg = 5 international units",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Treatment of ITP in Rh-positive patients with an intact spleen appears to be about as effective as IVIG.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     HyperRho S/D&reg; and RhoGAM&reg;, which are prepared using cold ethanol fraction and ultrafiltration, must be administered intramuscularly because trace amounts of IgA and other plasma proteins in the product could cause anaphylaxis if they were given intravenously. Rhophylac&reg; and WinRho SDF&reg; are prepared by ion-exchange chromatography isolation and are purer, allowing them to be given intramuscularly or intravenously.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Alade SL, Brown RE, and Paquet A Jr, \"Polysorbate 80 and E-Ferol Toxicity,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1986, 77(4):593-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/6/2151/abstract-text/3960626/pubmed\" id=\"3960626\" target=\"_blank\">",
"        3960626",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control (CDC), \"Unusual Syndrome With Fatalities Among Premature Infants: Association With a New Intravenous Vitamin E Product,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 1984, 33(14):198-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/6/2151/abstract-text/6423951/pubmed\" id=\"6423951\" target=\"_blank\">",
"        6423951",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gaines AR, &ldquo;Acute Onset Hemoglobinemia and/or Hemoglobinuria and Sequelae Following Rh(o)(D) Immune Globulin Intravenous Administration in Immune Thrombocytopenic Purpura Patients,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2000, 95(8):2523-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/6/2151/abstract-text/10753830 /pubmed\" id=\"10753830 \" target=\"_blank\">",
"        10753830",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shahgholi E, Vosough P, Sotoudeh K, et al, \"Intravenous Immune Globulin Versus Intravenous Anti-D Immune Globulin for the Treatment of Acute Immune Thrombocytopenic Purpura,\"",
"      <i>",
"       Indian J Pediatr",
"      </i>",
"      , 2008, 75(12):1231-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/6/2151/abstract-text/19190878/pubmed\" id=\"19190878\" target=\"_blank\">",
"        19190878",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tarantino MD, Young G, Bertolone SJ, et al, \"Single Dose of Anti-D Immune Globulin at 75 Microg/kg Is as Effective as Intravenous Immune Globulin at Rapidly Raising the Platelet Count in Newly Diagnosed Immune Thrombocytopenic Purpura in Children,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2006, 148(4):489-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/6/2151/abstract-text/16647411/pubmed\" id=\"16647411\" target=\"_blank\">",
"        16647411",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12762 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.170.48.130-F42F8ABDFE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2151=[""].join("\n");
var outline_f2_6_2151=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9838303\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217876\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217877\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061830\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061824\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217855\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217839\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061833\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061827\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061832\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217896\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061837\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061823\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061822\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299995\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217848\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217851\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217863\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061829\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061821\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061835\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061836\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2876784\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1061838\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12762\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12762|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/58/11175?source=related_link\">",
"      Rho(D) immune globulin (intramuscular): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?8/38/8804?source=related_link\">",
"      Rho(D) immune globulin (intramuscular): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_6_2152="Urinary system location anterior view";
var content_f2_6_2152=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Urinary system location: Anterior perspective",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 421px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The picture above depicts the urinary system in situ and its relationship to the skeleton from an anterior perspective.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: LifeART. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2152=[""].join("\n");
var outline_f2_6_2152=null;
var title_f2_6_2153="Atrial septal embryology";
var content_f2_6_2153=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77749&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77749&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Development of the Atrial Septum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 629px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2153=[""].join("\n");
var outline_f2_6_2153=null;
var title_f2_6_2154="Pregnancy outcome after assisted reproductive technology";
var content_f2_6_2154=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pregnancy outcome after assisted reproductive technology",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/6/2154/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/6/2154/contributors\">",
"     Richard Paulson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/6/2154/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/6/2154/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/6/2154/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/6/2154/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/6/2154/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/6/2154/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first pregnancy after in vitro fertilization (IVF) of a human egg and the first birth of an in vitro-fertilized baby were reported in 1976 and 1978, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Since then, over four million pregnancies have been achieved worldwide by IVF and its modifications. These procedures are known generically as assisted reproductive techniques (ART) and include gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT).",
"   </p>",
"   <p>",
"    As experience has accumulated, ART success rates have increased and the indications for these procedures have expanded. Registry data from the United States for 2009 described 45,870 deliveries of 60,190 infants [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/3\">",
"     3",
"    </a>",
"    ]. Approximately 1 percent of all deliveries and about 20 percent of all multiple births in the United States are the result of ART. In Belgium and Denmark, ART infants comprised 3.5 percent of births [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Concerns about the outcome of these pregnancies have accompanied their increasing prevalence. Both short and long-term outcomes have been studied and the findings are generally reassuring [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. However, research in this field is complicated by the need to distinguish between the effects of ART on outcomes in offspring versus multiple other confounding or mediating factors. Furthermore, these outcomes are influenced by technological changes in the performance of ART, as well as changes in obstetrical and neonatal care, over time [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The outcome of pregnancies conceived by ART will be discussed here. An in depth discussion of IVF and intracytoplasmic sperm injection (ICSI) procedures themselves can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=see_link\">",
"     \"In vitro fertilization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=see_link\">",
"     \"Intracytoplasmic sperm injection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREGNANCY RATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy rates after ART are influenced by a variety of factors, which are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=see_link&amp;anchor=H4#H4\">",
"     \"In vitro fertilization\", section on 'Pre-cycle factors associated with success'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=see_link&amp;anchor=H28#H28\">",
"     \"In vitro fertilization\", section on 'Pregnancy rate'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREGNANCY OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conception by IVF is associated with an increased incidence of several obstetrical and perinatal complications. Most of these are related to the high incidence of multiple gestations. Whereas multiple gestations achieved by IVF appear to have similar outcomes to those of multiple gestations conceived spontaneously, singleton pregnancies after IVF are associated with an increased incidence of complications [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/7\">",
"     7",
"    </a>",
"    ]. The precise reasons for this increase in adverse outcomes are not clear, but potential candidates include: maternal and paternal characteristics, underlying medical conditions associated with subfertility and infertility, sperm factors, the use of fertility medications, laboratory conditions during embryo culture, culture medium, cryopreservation and thawing, prenatal genetic diagnosis (if performed), differences in obstetrical management, increased proportion of multiple gestations and vanishing twins, or a combination of these factors. The effects of advanced maternal age also need to be considered since many women who undergo IVF are older and older women are more likely to have pregnancy complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/7/31865?source=see_link\">",
"     \"Effect of advanced age on fertility and pregnancy in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Potential adverse outcomes in singleton IVF pregnancies are discussed in detail below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Early loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early spontaneous pregnancy loss is common in pregnancies conceived naturally and with ART, and the rate of loss is similar for both methods of conception [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. In studies of serial ultrasound examination from initial diagnosis of very early pregnancies conceived by IVF, spontaneous loss of at least one gestation occurred in about 25 percent of singleton pregnancies, 35 percent of twin pregnancies, and 55 percent of triplet pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    It has been hypothesized that the slightly increased risk of adverse outcomes in singleton gestations conceived with ART (see below) is due to the high proportion of singletons that result from vanishing twins or triplets [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/7,11-14\">",
"     7,11-14",
"    </a>",
"    ]. In the SART database of 21,535 singleton deliveries conceived by ART, 8 percent originated from a twin or triplet gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/13\">",
"     13",
"    </a>",
"    ]. Compared to pregnancies with one fetal heartbeat on early ultrasound examination, early loss of a sonographically identified second or third fetal heartbeat significantly increased the odds of preterm birth and low birthweight for gestational age, and the risk increased in proportion to the number of fetal heartbeats lost. Using the same SART database, the authors reported similar findings for twin deliveries that experienced early loss of a third fetal heartbeat [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, studies have not consistently observed an adverse effect from early spontaneous loss of one twin [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/16\">",
"     16",
"    </a>",
"    ]. Furthermore, numerous other factors related to subfertility or the IVF procedure could be contributing to the small increase in adverse outcomes described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Spontaneous abortion",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2009, results generated from the CDC database showed spontaneous abortion occurred in 16.4 percent of pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/3\">",
"     3",
"    </a>",
"    ]. As is the case with pregnancy rates, spontaneous abortion rates are strongly influenced by the age of the egg provider, with lesser effects from the underlying cause of infertility. Studies have shown that spontaneous abortion rate after ART (IVF with or without ICSI) is the same as for the general population of the United States when fresh fertilized embryos are used and adjustments are made for age and multiple gestation, but the rate may be somewhat higher with thawed embryos [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ectopic pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CDC database showed that 0.6 percent of cycles resulted in an ectopic pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/3\">",
"     3",
"    </a>",
"    ]. Ectopic risk among ART pregnancies varies according to the type of procedure (eg, higher with zygote intrafallopian transfer or ZIFT) and reproductive health characteristics of the woman carrying the pregnancy (eg, higher in those with tubal factor infertility) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/19\">",
"     19",
"    </a>",
"    ]. As an example, in this study, standard IVF and transcervical embryo transfer resulted in 2.2 percent rate of ectopic pregnancy, whereas embryo transfer to a gestational surrogate was associated with only a 0.9 percent risk of ectopic pregnancy, a rate similar to that in spontaneous pregnancies.",
"   </p>",
"   <p>",
"    Heterotopic pregnancy is far more common in pregnancies conceived by ART than spontaneous conceptions",
"    <span class=\"nowrap\">",
"     (1/100",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     1/30,000).",
"    </span>",
"    This increase mirrors the dramatic increase in multiple gestations after IVF due to the transfer of multiple embryos. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/15/21752?source=see_link&amp;anchor=H27#H27\">",
"     \"Incidence, risk factors, and pathology of ectopic pregnancy\", section on 'Heterotopic pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Proportion of singleton and multiple gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased implantation rates have resulted in both increased overall success rates as well as increased multiple gestation rates. Worldwide, IVF resulted in twin and triplet pregnancy birth rates of about 27 and 3 percent, respectively, in 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/20\">",
"     20",
"    </a>",
"    ]. ART is estimated to account for just over 1 percent of all births in the United States and 20 percent of all multiple births. Among women undergoing IVF with fresh nondonor embryos in 2009, the rates of singleton, twin, and triplets-or-more pregnancies were 61.7, 28.5, and 3.1 percent, respectively (6.7 percent undetermined at early miscarriage) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/3\">",
"     3",
"    </a>",
"    ]. There is a lower proportion of high order multiples among live births due to the higher rate of spontaneous and induced (fetal reduction procedures) loss among these pregnancies. The proportion of singleton, twin, and triplets-or-more live births was 69.5, 28.9, and 1.6 percent, respectively.",
"   </p>",
"   <p>",
"    Strategies to reduce the risks of multiple gestation and multifetal pregnancy reduction are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/27/43449?source=see_link\">",
"     \"Strategies to control the rate of high order multiple gestation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39065?source=see_link\">",
"     \"Multifetal pregnancy reduction and selective termination\"",
"    </a>",
"    .) (Also, see topic reviews on twin and triplet pregnancies).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Monozygotic multiples",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most multiple gestations are multizygotic and result from transfer of multiple embryos, the frequency of monozygotic multiples is also increased from approximately 0.4 percent to 1 to 5 percent of pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/21\">",
"     21",
"    </a>",
"    ]. In one large series, the frequency of monochorionic-diamniotic implantations was increased, but the frequency of monochorionic-monoamniotic implantations was not; dichorionic-diamniotic implantations were not assessed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/22\">",
"     22",
"    </a>",
"    ]. The increase in monozygotic twinning has been attributed to the in vitro culture environment and to extended duration of culture. Embryo manipulation, such as ICSI or assisted hatching, may or may not contribute to the risk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Preterm birth, LBW, and SGA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Singleton IVF pregnancies, with or without ICSI, are at higher risk of preterm birth and low birth weight (LBW, &le;2500 g) compared to spontaneously conceived pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/7,24-33\">",
"     7,24-33",
"    </a>",
"    ]. In 2009, the frequency of preterm birth by plurality was 11.6 percent for singletons, 19.0 percent for singletons from multiple-fetus pregnancies, 60.0 percent of twins, and 97.5 percent for triplets or more [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/3\">",
"     3",
"    </a>",
"    ]. For LBW, the percentages were 8.7, 16.7, 56.1 and 92.1 percent, respectively.",
"   </p>",
"   <p>",
"    Two large studies by the same group, whose findings are similar to those generally reported in the literature, illustrate these risks [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first, population-based data from over 42,000 infants conceived with ART from 1996 to 1997 and 3 million births in the general population showed the following findings [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/7\">",
"       7",
"      </a>",
"      ]: LBW was significantly more common among term singleton, but not twin, infants conceived by ART compared with the general population (for singletons 6.5 versus 2.5 percent; RR 2.6, 95% CI 2.4-2.7) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/7\">",
"       7",
"      </a>",
"      ]. Preterm LBW was also significantly more common among singleton, but not twin, infants conceived by ART (for singletons 6.6 versus 4.7 percent; RR 1.4, 95% CI 1.3-1.5).",
"      <br/>",
"      <br/>",
"      The increased risk persisted after adjustment for maternal age and parity, gestational age at delivery, multifetal reduction procedures, and cause of infertility. The lack of a strong association between IVF and preterm birth in twins in this and subsequent studies [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/28,29,34,35\">",
"       28,29,34,35",
"      </a>",
"      ] may be due to confounding factors, such as the much higher proportion of monozygotic twins (who are at increased risk of preterm birth and low birth weight) among spontaneously conceived gestations. In one study, the dizygotic:monozygotic ratio in twins conceived by assisted reproduction versus naturally conceived twins was 95:5 and 54:46, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/36\">",
"       36",
"      </a>",
"      ]. It is possible that the profound effect that twinning has on pregnancy outcome overshadows any additional effect that IVF may exert. These data may also be interpreted as supporting the contention that an increase in adverse outcomes among singletons is due to the \"vanishing twin\" phenomenon described above.",
"     </li>",
"     <li>",
"      An extended follow-up study included over 62,000 singleton infants from ART procedures from 1996 to 2000 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/37\">",
"       37",
"      </a>",
"      ]. Over this interval, there was a decline in LBW deliveries, but no significant change in the rate of preterm birth. Although the frequency of LBW declined, it was still higher than the expected rate adjusted for age, parity, and",
"      <span class=\"nowrap\">",
"       race/ethnicity.",
"      </span>",
"      Clear reasons for the fall in LBW and the persistent increased risk of preterm birth were not identified.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, meta-analyses comprising several thousand IVF and approximately two million spontaneously conceived singleton births matched for maternal age and parity found IVF pregnancies were at significantly higher risk of preterm delivery (OR 1.95-1.98) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/27,30\">",
"     27,30",
"    </a>",
"    ], LBW (OR 1.77, 95% CI 1.40-2.22), and small for gestational age (SGA) infants (OR 1.6; 95% CI 1.3-2.0) (",
"    <a class=\"graphic graphic_table graphicRef53754 \" href=\"UTD.htm?27/47/28411\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/27\">",
"     27",
"    </a>",
"    ]. The increased risk of preterm delivery remained when only preterm births after spontaneous labor were considered [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/27\">",
"     27",
"    </a>",
"    ]. Although there was significant heterogeneity among studies, subgroup analysis of studies with similar designs consistently yielded ORs similar to the overall summary OR.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Conclusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;These results suggest that ART is associated with an up to two-fold increased risk of preterm birth and low birth weight in singleton pregnancies. There are several potential explanations for the difference in outcome between ART and naturally conceived pregnancies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It could be related to the ART procedure (drugs, manipulation of gametes and embryos, culture, effect of ovarian stimulation on endometrial receptivity), although a physiological mechanism explaining how the procedures and drugs used in ART increase the risk of LBW has not been determined.",
"     </li>",
"     <li>",
"      There are probably treatment biases in studies of IVF pregnancies, as these pregnancies can be associated with excessive parental anxiety (\"premium pregnancy\") and are more common in couples of higher socioeconomic status. As a result, they are likely to undergo more intense monitoring and more frequent intervention, such as a higher rate of elective cesarean delivery (11.4 versus 6.7 percent in spontaneously conceived singletons). However, very LBW (&lt;1500 g) is unlikely to be the result of elective preterm delivery, and this outcome is also more common among singletons conceived through ART [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/7,27,28\">",
"       7,27,28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Subfertility appears to have an adverse affect on pregnancy outcome, independent of its treatment. Several studies have reported that women with untreated subfertility who became pregnant had a greater frequency of adverse outcomes than the general population [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/38-42\">",
"       38-42",
"      </a>",
"      ], and their frequency of complications was similar to that in subfertile women who underwent ART [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/43\">",
"       43",
"      </a>",
"      ] .All of the studies were observational and many potential confounders were not considered in the analyses.",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    More compelling support for this latter hypothesis was provided by a population-based cohort study that compared the pregnancy outcome of multiparous women who underwent ART with the pregnancy outcome of (1) the same women in a previous or subsequent naturally conceived pregnancy, and (2) the general obstetrical population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/44\">",
"     44",
"    </a>",
"    ]. Multiparous women who underwent ART had infants of similar gestational age and birth weight in pregnancies before and after the procedure, but their infants delivered earlier and had lower birth weights than the general obstetrical population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Developmental issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, neurodevelopmental outcomes of children conceived by ART appear to be normal [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/45\">",
"     45",
"    </a>",
"    ]. However, studies are limited by methodological issues such as insufficient numbers of children followed through school age, possible selection biases, and inadequate control groups. Although ART does not appear to be an independent risk factor for adverse neurodevelopment outcome, the procedure does result in more multiple gestations, which are at high risk of preterm birth and low birth weight, the two most important risk factors for neurodevelopmental sequelae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Cerebral palsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not clear whether ART is an independent risk factor for development of cerebral palsy. A meta-analysis of three studies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/33,46,47\">",
"     33,46,47",
"    </a>",
"    ] including over 19,000 children conceived via IVF and over 430,000 children conceived naturally noted an association between IVF and cerebral palsy (OR 2.18, 95% CI 1.71-2.77) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/48\">",
"     48",
"    </a>",
"    ]. However, most if not all of the increased risk of cerebral palsy appeared to be mediated by the high frequency of low birth",
"    <span class=\"nowrap\">",
"     weight/preterm",
"    </span>",
"    birth and multiple gestation in the IVF group. The authors postulated that maternal subfertility or early demise of a co-twin (vanishing twin) might also play a role. However, at least one subsequent well-designed observational study observed a small but statistically significant association between IVF or ICSI and development of cerebral palsy, even after adjusting for multiple gestation and prematurity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/49\">",
"     49",
"    </a>",
"    ]. Subfertility did not appear to be a risk factor. There is as yet no hypothesis for a physiologic mechanism for these observations and a cause-and-effect relationship has not been established. As with any epidemiologic study, detection and diagnostic bias may have played a role in these findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Intraventricular hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;One case-control study compared infants with intraventricular hemorrhage (IVH) to controls matched for gestational age, birth weight, and multiple gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/50\">",
"     50",
"    </a>",
"    ]. There was a significant increase in the risk of grade",
"    <span class=\"nowrap\">",
"     III/IV",
"    </span>",
"    IVH in infants exposed to fertility treatments (mostly IVF). This finding requires further investigation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Psychosocial development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mothers of children conceived via ART generally report less parenting stress and more positive mother- and father-child relationships than mothers of naturally conceived children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Follow-up studies to as long as 18 years of age show that children conceived via ART are similar to naturally conceived children in terms of emotional development, behavior, self-esteem, perceptions of family relationships, and cognitive development [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/51,53-58\">",
"     51,53-58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A potential confounder in these comparative studies is that all IVF pregnancies are planned, whereas as many as 50 percent of natural conceptions are unplanned.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Cognitive and motor development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Series including over 1000 children aged up to 10 years described similar developmental outcomes (cognitive and motor) in children born after IVF with and without ICSI [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/59-61\">",
"     59-61",
"    </a>",
"    ]. Furthermore, developmental outcome appeared to be the same as for naturally conceived children. Although an earlier study reported poorer Bayley developmental scores in children conceived by ICSI versus IVF [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/62\">",
"     62",
"    </a>",
"    ], when the same authors reassessed children at five years using the Wechsler Preschool and Primary Scale of Intelligence, they found no differences among ICSI, IVF, and naturally conceived children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. These data, and subsequent studies of children up to age 17 years, are reassuring that IVF with or without ICSI is not associated with cognitive or developmental delay or",
"    <span class=\"nowrap\">",
"     psychological/behavioral",
"    </span>",
"    issues [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/51,53,59-61,65-67\">",
"     51,53,59-61,65-67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Pubertal development",
"      </strong>",
"      &mdash; There has been a single report of seven children (six girls and one boy) age 5 to 21 months referred to a pediatric endocrine department because of premature thelarche and pubarche [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/68\">",
"       68",
"      </a>",
"      ]. Sex steroid levels were in the normal prepubertal range and ultrasound examinations of the gonads and adrenals were normal. All of the children were products of ART; however, there was no analysis as to whether the association with ART was higher than expected. The abnormality has not been previously reported. Further study is required before pseudoprecocious puberty can be considered a possible outcome of ART.",
"      <br/>",
"      <br/>",
"      A longitudinal study of a cohort of ICSI-conceived teenagers compared pubertal development at age 14 years in this cohort with a spontaneously conceived control group [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/69\">",
"       69",
"      </a>",
"      ]. Menarche, genital development in males, and pubic hair development in males and females was comparable in both groups, while breast developmental was less advanced in ICSI females compared with spontaneously conceived peers, even after adjustment for known potential confounders.",
"     </li>",
"     <li>",
"      <strong>",
"       Autism spectrum disorders",
"      </strong>",
"      &mdash; Studies of the association of autism spectrum disorders and ART have reported inconsistent findings [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/48,70\">",
"       48,70",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Congenital anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who undergo ART appear to be at increased risk of delivering offspring with congenital malformations compared with fertile women who conceive naturally, but the reason for this increase is unclear. It may be related to infertility itself or to factors related to ART procedures, or both. Vanishing twins or other unappreciated differences between patients and controls may also play a role. Regardless, patients can be reassured that the absolute risk of having a child with a congenital anomaly is low; the population baseline risk of 2 to 4 percent is potentially increased by about one-third with ART.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The increased risk of birth defects was supported by a meta-analysis of 46 epidemiologic studies with data on birth defects in children conceived by IVF",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ICSI (n = 124,468 infants) compared with spontaneously conceived children [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/71\">",
"       71",
"      </a>",
"      ]. Major findings were:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The pooled risk of birth defects in offspring conceived with ART was significantly increased (RR 1.37, 95% CI 1.26-1.48).",
"     </li>",
"     <li>",
"      The increased risk of birth defects was observed for all major organ systems, and was highest for the nervous system (RR 2.01, 95% CI 1.27-3.20).",
"     </li>",
"     <li>",
"      When children conceived by IVF (n = 46,890) were compared with those conceived by ICSI (n = 27,754), there was no significant risk difference related to ICSI (RR 1.05, 95% CI -0.91 to 1.20).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There was considerable heterogeneity among these studies, including differences in factors that could increase the rate of birth defects: age of mother, cause of infertility, prior treatment for infertility, duration of infertility, environmental exposures, risk behaviors such as alcohol and smoking, and the ART procedures themselves. The importance of patient factors in the risk of birth defects after fertility therapy is illustrated by the following study.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A large well-designed observational study in South Australia linked a census of treatment with ART to registries of births, terminations, and birth defects [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/72\">",
"       72",
"      </a>",
"      ]. The risk of birth defects by age 5 was compared for pregnancies conceived: with ART, spontaneously but with previous history of infertility and birth by ART, spontaneously with no history of infertility, and history of infertility but treatment other than ART. There were 308,974 births of which 6163 resulted from ART. Birth defects included anatomic abnormalities, as well as cerebral palsy, biochemical abnormalities, and genetic diseases. Major findings were:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The unadjusted risk for any birth defect in pregnancies involving ART was increased compared with pregnancies not involving ART (513 defects, 8.3 percent versus 17,546 defects 5.8 percent; OR 1.47, 95% CI 1.33-1.62). The increase persisted in multivariate analysis (OR 1.28, 95% CI 1.16-1.41).",
"     </li>",
"     <li>",
"      Compared to spontaneous conception in fertile women, the odds of offspring with a birth defect were increased with IVF (165 birth defects, 7.2 percent; unadjusted OR 1.26, 95% CI 1.07-1.48) and ICSI (139 defects, 9.9 percent, unadjusted OR 1.77, 95% CI 1.47-2.12).",
"     </li>",
"     <li>",
"      However, when the risk of birth defects was adjusted for patient factors (eg, maternal age, parity, fetal sex, year of birth, maternal",
"      <span class=\"nowrap\">",
"       race/ethnicity,",
"      </span>",
"      smoking, occupation, maternal conditions during pregnancy), IVF was not associated with an increased risk of birth defects compared with spontaneous conception in fertile women (adjusted OR 1.07, 95% CI 0.90-1.26), while the risk associated with ICSI remained increased (adjusted OR 1.57, 95% CI 1.30-1.90).",
"     </li>",
"     <li>",
"      A history of infertility was associated with an increased risk of birth defects in offspring, whether infertility was treated with ART or treated with therapies other than ART.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Chromosomal and genetic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are sparse, studies have not shown a higher prevalence of karyotype abnormalities (including mosaicism) in offspring of IVF conceived pregnancies than in naturally conceived pregnancies, and prenatal diagnosis is not typically offered for this indication alone [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there is concern that use of sperm from subfertile men and the ICSI procedure itself [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/75\">",
"     75",
"    </a>",
"    ] may increase the risk of chromosomal and gene abnormalities in children conceived by ART. Subfertile men (and women) are more likely than fertile individuals to have chromosomal abnormalities (eg, aneuploidies, structural abnormalities, gene mutations, microdeletions) that may contribute to their subfertility and may be passed to their offspring. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=see_link&amp;anchor=H27#H27\">",
"     \"Intracytoplasmic sperm injection\", section on 'Chromosomal abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It was hypothesized that preimplantation genetic screening would improve the rate of successful pregnancy in women undergoing IVF, particularly those with repeated IVF failure, because only chromosomally normal embryos would be transferred. However, randomized trials have disproved this theory, although preimplantation genetic diagnosis for individuals at specific risk for an inherited disease is supported (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23431?source=see_link\">",
"     \"Preimplantation genetic diagnosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Imprinting disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genomic imprinting is a process by which genes from only one parental allele are expressed. At least 70 genes in which active transcription is normally limited to only one allele have been identified. These genes involve early embryonic growth, placental development and neurodevelopment. Generally, specific imprinted genes promoting fetal development are often active from only the maternal allele, while other imprinted genes promoting placental growth are active from only the paternal allele.",
"   </p>",
"   <p>",
"    Abnormalities of the imprinting process can be caused by several molecular mechanisms, including DNA mutations of an imprinted gene,",
"    <span class=\"nowrap\">",
"     deletion/duplication",
"    </span>",
"    of regions of the chromosome containing the imprinted gene, uniparental disomy, and changes in DNA methylation.",
"   </p>",
"   <p>",
"    Concerns have been raised that ART may affect imprinted genes. The basis for this concern is that imprints are established during meiosis, typically with alterations of methylation at the specific allele that render it silent. In the female, meiosis I occurs at ovulation and meiosis II is completed at fertilization, thus, both meiosis I and II occur during events that may be vulnerable to processes and manipulations related to ART. Imprinting syndromes are rare (fewer than 1 in 12,000 births), thus even a several-fold increase in relative risk represents a small absolute risk and would be difficult to detect.",
"   </p>",
"   <p>",
"    There are nine known imprinting syndromes. Given the rarity of these disorders, it is difficult to determine whether they may be related to some aspect of the ART procedure or subfertility itself or a combination of factors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/76\">",
"     76",
"    </a>",
"    ]. A review of epidemiological studies concluded that Beckwith-Wiedemann syndrome was significantly associated with",
"    <span class=\"nowrap\">",
"     IVF/ICSI,",
"    </span>",
"    Silver-Russell syndrome was probably associated with",
"    <span class=\"nowrap\">",
"     IVF/ICSI,",
"    </span>",
"    and Angelman and Prader-Willi syndrome were not associated with",
"    <span class=\"nowrap\">",
"     IVF/ICSI",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/77\">",
"     77",
"    </a>",
"    ]. The authors noted that the incidences of Angelman syndrome and Prader-Willi syndrome were positively associated with subfertility and concluded that, &ldquo;there are no indications for a causal relationship between ART and imprinted diseases in humans.&rdquo;",
"   </p>",
"   <p>",
"    Detailed reviews on the association between ART and defects of genomic imprinting can be found separately [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/78-83\">",
"     78-83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24473?source=see_link\">",
"     \"Beckwith-Wiedemann syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=see_link\">",
"     \"Intracytoplasmic sperm injection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=see_link&amp;anchor=H1497302#H1497302\">",
"     \"Basic principles of genetic disease\", section on 'Imprinting'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been hypothesized that defective imprinting may have a role in the development of some childhood cancers, such as Wilms tumor, retinoblastoma, and embryonal rhabdomyosarcoma. As discussed above, the epigenetic phenomenon of imprinting may be affected by ART, especially by the more invasive procedures, such as ICSI, in vitro maturation, assisted hatching and blastocyst transfer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=see_link\">",
"     \"Intracytoplasmic sperm injection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Multiple studies have not demonstrated an increase in cancer risk among children conceived by IVF [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/84-88\">",
"     84-88",
"    </a>",
"    ]. Although one report from the Netherlands noted the relative risk of retinoblastoma was increased in these offspring (RR 2.54, 95% CI 1.02&ndash;5.23), the absolute risk was low (seven cases among all IVF births conceived from 1995 to 2007); the significantly elevated risk was restricted to the period 1995-2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/89\">",
"     89",
"    </a>",
"    ], not for 2002&ndash;2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/90\">",
"     90",
"    </a>",
"    ]; and none of the tumors showed hypermethylation of the RB1 promoter as an epigenetic mechanism for development of the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/91\">",
"     91",
"    </a>",
"    ]. The estimated baseline population risk of retinoblastoma is",
"    <span class=\"nowrap\">",
"     2.6/100,000",
"    </span>",
"    children under one year of age.",
"   </p>",
"   <p>",
"    Case reports and case control studies have also described children who developed cancer and were conceived by IVF or ICSI. A major problem with all of these studies is that they are based upon small numbers, and often subject to recall bias [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/92\">",
"     92",
"    </a>",
"    ]. Better data come from pooled results from four cohort studies that reported cancer incidence in ART children and provided sufficient information for analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/84,85,87,93\">",
"     84,85,87,93",
"    </a>",
"    ]. The standard incidence ratio (the ratio of the number of events observed in a sample population to the number that would be expected in the overall population) was not significantly increased, 1.03 (95% CI, 0.61 to 1.63) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/92\">",
"     92",
"    </a>",
"    ]. A meta-analysis including 11 cohort studies also reported no significant increase in risk of childhood cancer in children conceived by ART, overall standard incidence ratio 1.33, 95% CI 0.62-2.85 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/94\">",
"     94",
"    </a>",
"    ]. However, these results are not definitive, as these studies were too small to detect small differences in the rate of rare events and follow-up ranged for only 1 to 13 years.",
"   </p>",
"   <p>",
"    The first study to demonstrate a small but statistically significant increase in cancer risk included 26,692 children conceived by IVF and born from 1982 to 2005 in Sweden [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/95\">",
"     95",
"    </a>",
"    ]. Cancer risk was assessed using data from the Swedish Cancer Registry and showed an estimated total cancer risk of 1.42 (95% CI 1.09 &ndash;1.87) through 2006. There were 53 cases of cancer in children who were born after IVF versus 38 expected cases. The 53 cases consisted of 18 hematologic cancers (15 acute lymphoblastic leukemia), 17 eye or central nervous system tumors, 12 solid cancers, and 6 cases of Langerhans histiocytosis. The authors hypothesized that the increased cancer risk was not due to the IVF procedure itself, but was related to unidentified confounders.",
"   </p>",
"   <p>",
"    The possibility of an increase in the risk of ovarian and breast cancer in women receiving gonadotropin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    therapy is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Obstetrical complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even among singleton gestations, an increased risk of pregnancy complications such as placenta previa and abruption, gestational diabetes, preeclampsia, fetal growth restriction and cesarean delivery has been associated with IVF; however, the absolute increase in risk has generally been small and most such pregnancies have normal outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/27,73,96-98\">",
"     27,73,96-98",
"    </a>",
"    ]. As discussed above, there are biases in observational studies of IVF pregnancies that account for some or all of these findings. While maternal age is considered by these studies, contributors such as the cause of infertility are not consistently ascertained and adjusted for when interpreting pregnancy outcome data. As an example, polycystic ovary syndrome (PCOS) is a common cause of infertility and is associated with insulin resistance, which plays a major role in development of gestational diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Perinatal mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stillbirth [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/99\">",
"     99",
"    </a>",
"    ] and perinatal mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/27\">",
"     27",
"    </a>",
"    ] rates appear to be increased as much as four-fold due, at least in part, to the obstetrical complications discussed above, low birth weight, and multiple gestation. In 2009, the stillbirth rate in the US after IVF was 0.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1750985980\">",
"    <span class=\"h2\">",
"     Sex ratio at birth",
"    </span>",
"    &nbsp;&mdash;&nbsp;ART procedures appear to have a small, but statistically significant, effect on the ratio of male-to-female births. The male-to-female ratio is about 10 percent lower after ICSI than after IVF [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/100,101\">",
"     100,101",
"    </a>",
"    ]. This has been hypothesized to be due to the higher proportion of male infertility among ICSI patients and to iatrogenic factors related to ICSI, both of which might lead to fewer males in ICSI conceived pregnancies. A higher male-to-female ratio after blastocyst transfer than after cleavage-stage transfer has also been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/100-102\">",
"     100-102",
"    </a>",
"    ]. Since embryos are selected for transfer on the basis of the degree of cleavage in addition to morphological evaluation, one theory is that male embryos divide faster.",
"   </p>",
"   <p>",
"    These relationships were illustrated in a retrospective population-based study of over 15,000 singleton infants in the Society for Assisted Reproductive Technology national database for 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/100\">",
"     100",
"    </a>",
"    ]. The male- to-female ratios after IVF blastocyst transfer and ICSI blastocyst transfer were 54.9 and 49.6 percent, respectively. The male-to-female sex ratio for blastocyst and cleavage stage embryos was 51.6 and 48.9 percent, respectively. By comparison, the male-to-female ratio in the general US population for the same year was 51.2 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2241569\">",
"    <span class=\"h2\">",
"     Other long-term issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;One study reported an increase in systemic and pulmonary vascular dysfunction in children after ART; in that study, a total of 65 children conceived by ART were evaluated at a mean age of 11.1 years and were found to have a degree of endothelial dysfunction that was statistically significantly greater than that of naturally conceived controls [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/103\">",
"     103",
"    </a>",
"    ]. These findings need verification. The biological mechanism for this putative effect is not clear, and may be related to confounders.",
"   </p>",
"   <p>",
"    Two studies reported an increased risk of asthma in children conceived by ART [",
"    <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/104,105\">",
"     104,105",
"    </a>",
"    ]. At least part of the association seems to be attributable to subfertility, neonatal morbidity related to prematurity, and maternal asthma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients should be informed that pregnancies conceived by ART are associated with increased risks of multiple gestations, congenital anomalies, preterm delivery, low birth weight, and the complications associated with these outcomes [",
"      <a class=\"abstract\" href=\"UTD.htm?2/6/2154/abstract/106,107\">",
"       106,107",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Even for singleton ART pregnancies, the relative risk of common pregnancy complications such as fetal growth restriction, preeclampsia, prematurity and perinatal mortality are increased, although not clearly independent of infertility itself. Neurodevelopmental outcomes of children conceived by ART appear to be normal compared to matched controls.",
"     </li>",
"     <li>",
"      Additional information on outcomes of multiple gestations can be found elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27594?source=see_link\">",
"       \"Neonatal outcome, complications, and management of multiple births\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/34/12842?source=see_link\">",
"       \"Triplet pregnancy: Mid and late pregnancy complications and management\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/1\">",
"      Steptoe PC, Edwards RG. Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet 1976; 1:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/2\">",
"      Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978; 2:366.",
"     </a>",
"    </li>",
"    <li>",
"     SART 2009 report file://www.cdc.gov/ART/ART2009 (Accessed on February 23, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/4\">",
"      Nyboe Andersen A, Goossens V, Bhattacharya S, et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2009; 24:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/5\">",
"      Wilson CL, Fisher JR, Hammarberg K, et al. Looking downstream: a review of the literature on physical and psychosocial health outcomes in adolescents and young adults who were conceived by ART. Hum Reprod 2011; 26:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/6\">",
"      Allen VM, Wilson RD, Cheung A, et al. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006; 28:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/7\">",
"      Schieve LA, Meikle SF, Ferre C, et al. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002; 346:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/8\">",
"      La Sala GB, Nucera G, Gallinelli A, et al. Spontaneous embryonic loss following in vitro fertilization: incidence and effect on outcomes. Am J Obstet Gynecol 2004; 191:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/9\">",
"      Dickey RP, Taylor SN, Lu PY, et al. Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. Am J Obstet Gynecol 2002; 186:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/10\">",
"      Kovacs GT, Breheny S, Maclachlan V, et al. Outcome of pregnancies achieved by in vitro fertilisation techniques and diagnosed as twins at the 6 week ultrasound. Aust N Z J Obstet Gynaecol 2004; 44:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/11\">",
"      Pinborg A, Lidegaard O, la Cour Freiesleben N, Andersen AN. Consequences of vanishing twins in IVF/ICSI pregnancies. Hum Reprod 2005; 20:2821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/12\">",
"      Chasen ST, Luo G, Perni SC, Kalish RB. Are in vitro fertilization pregnancies with early spontaneous reduction high risk? Am J Obstet Gynecol 2006; 195:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/13\">",
"      Luke B, Brown MB, Grainger DA, et al. The effect of early fetal losses on singleton assisted-conception pregnancy outcomes. Fertil Steril 2009; 91:2578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/14\">",
"      Pinborg A, Lidegaard O, Freiesleben Nl, Andersen AN. Vanishing twins: a predictor of small-for-gestational age in IVF singletons. Hum Reprod 2007; 22:2707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/15\">",
"      Luke B, Brown MB, Grainger DA, et al. The effect of early fetal losses on twin assisted-conception pregnancy outcomes. Fertil Steril 2009; 91:2586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/16\">",
"      La Sala GB, Villani MT, Nicoli A, et al. Effect of the mode of assisted reproductive technology conception on obstetric outcomes for survivors of the vanishing twin syndrome. Fertil Steril 2006; 86:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/17\">",
"      Schieve LA, Tatham L, Peterson HB, et al. Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet Gynecol 2003; 101:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/18\">",
"      Pezeshki K, Feldman J, Stein DE, et al. Bleeding and spontaneous abortion after therapy for infertility. Fertil Steril 2000; 74:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/19\">",
"      Clayton HB, Schieve LA, Peterson HB, et al. Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol 2006; 107:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/20\">",
"      International Committee for Monitoring Assisted Reproductive Technology, Adamson GD, de Mouzon J, et al. World collaborative report on in vitro fertilization, 2000. Fertil Steril 2006; 85:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/21\">",
"      Derom C, Vlietinck R, Derom R, et al. Increased monozygotic twinning rate after ovulation induction. Lancet 1987; 1:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/22\">",
"      Knopman J, Krey LC, Lee J, et al. Monozygotic twinning: an eight-year experience at a large IVF center. Fertil Steril 2010; 94:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/23\">",
"      Das S, Blake D, Farquhar C, Seif MM. Assisted hatching on assisted conception (IVF and ICSI). Cochrane Database Syst Rev 2009; :CD001894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/24\">",
"      Lambalk CB, van Hooff M. Natural versus induced twinning and pregnancy outcome: a Dutch nationwide survey of primiparous dizygotic twin deliveries. Fertil Steril 2001; 75:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/25\">",
"      Olivennes F, Rufat P, Andr&eacute; B, et al. The increased risk of complication observed in singleton pregnancies resulting from in-vitro fertilization (IVF) does not seem to be related to the IVF method itself. Hum Reprod 1993; 8:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/26\">",
"      Pregnancies and births resulting from in vitro fertilization: French national registry, analysis of data 1986 to 1990. FIVNAT (French In Vitro National). Fertil Steril 1995; 64:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/27\">",
"      Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/28\">",
"      Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 2004; 328:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/29\">",
"      Pinborg A, Loft A, Schmidt L, et al. Maternal risks and perinatal outcome in a Danish national cohort of 1005 twin pregnancies: the role of in vitro fertilization. Acta Obstet Gynecol Scand 2004; 83:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/30\">",
"      McGovern PG, Llorens AJ, Skurnick JH, et al. Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis. Fertil Steril 2004; 82:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/31\">",
"      Wang YA, Sullivan EA, Black D, et al. Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000. Fertil Steril 2005; 83:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/32\">",
"      Katalinic A, R&ouml;sch C, Ludwig M, German ICSI Follow-Up Study Group. Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study. Fertil Steril 2004; 81:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/33\">",
"      Klemetti R, Sev&oacute;n T, Gissler M, Hemminki E. Health of children born as a result of in vitro fertilization. Pediatrics 2006; 118:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/34\">",
"      Boulet SL, Schieve LA, Nannini A, et al. Perinatal outcomes of twin births conceived using assisted reproduction technology: a population-based study. Hum Reprod 2008; 23:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/35\">",
"      McDonald S, Murphy K, Beyene J, Ohlsson A. Perinatal outcomes of in vitro fertilization twins: a systematic review and meta-analyses. Am J Obstet Gynecol 2005; 193:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/36\">",
"      Verstraelen H, Goetgeluk S, Derom C, et al. Preterm birth in twins after subfertility treatment: population based cohort study. BMJ 2005; 331:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/37\">",
"      Schieve LA, Ferre C, Peterson HB, et al. Perinatal outcome among singleton infants conceived through assisted reproductive technology in the United States. Obstet Gynecol 2004; 103:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/38\">",
"      Draper ES, Kurinczuk JJ, Abrams KR, Clarke M. Assessment of separate contributions to perinatal mortality of infertility history and treatment: a case-control analysis. Lancet 1999; 353:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/39\">",
"      McElrath TF, Wise PH. Fertility therapy and the risk of very low birth weight. Obstet Gynecol 1997; 90:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/40\">",
"      Wang JX, Norman RJ, Kristiansson P. The effect of various infertility treatments on the risk of preterm birth. Hum Reprod 2002; 17:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/41\">",
"      Zhu JL, Obel C, Hammer Bech B, et al. Infertility, infertility treatment, and fetal growth restriction. Obstet Gynecol 2007; 110:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/42\">",
"      Cooper AR, O'Neill KE, Allsworth JE, et al. Smaller fetal size in singletons after infertility therapies: the influence of technology and the underlying infertility. Fertil Steril 2011; 96:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/43\">",
"      Raatikainen K, Kuivasaari-Pirinen P, Hippel&auml;inen M, Heinonen S. Comparison of the pregnancy outcomes of subfertile women after infertility treatment and in naturally conceived pregnancies. Hum Reprod 2012; 27:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/44\">",
"      Romundstad LB, Romundstad PR, Sunde A, et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008; 372:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/45\">",
"      Schieve LA, Rasmussen SA, Buck GM, et al. Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol 2004; 103:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/46\">",
"      Str&ouml;mberg B, Dahlquist G, Ericson A, et al. Neurological sequelae in children born after in-vitro fertilisation: a population-based study. Lancet 2002; 359:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/47\">",
"      Hvidtj&oslash;rn D, Grove J, Schendel DE, et al. Cerebral palsy among children born after in vitro fertilization: the role of preterm delivery--a population-based, cohort study. Pediatrics 2006; 118:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/48\">",
"      Hvidtj&oslash;rn D, Schieve L, Schendel D, et al. Cerebral palsy, autism spectrum disorders, and developmental delay in children born after assisted conception: a systematic review and meta-analysis. Arch Pediatr Adolesc Med 2009; 163:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/49\">",
"      Zhu JL, Hvidtj&oslash;rn D, Basso O, et al. Parental infertility and cerebral palsy in children. Hum Reprod 2010; 25:3142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/50\">",
"      Linder N, Haskin O, Levit O, et al. Risk factors for intraventricular hemorrhage in very low birth weight premature infants: a retrospective case-control study. Pediatrics 2003; 111:e590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/51\">",
"      Barnes J, Sutcliffe AG, Kristoffersen I, et al. The influence of assisted reproduction on family functioning and children's socio-emotional development: results from a European study. Hum Reprod 2004; 19:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/52\">",
"      Steiner AZ, Paulson RJ. Motherhood after age 50: an evaluation of parenting stress and physical functioning. Fertil Steril 2007; 87:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/53\">",
"      Papaligoura Z, Panopoulou-Maratou O, Solman M, et al. Cognitive development of 12 month old Greek infants conceived after ICSI and the effects of the method on their parents. Hum Reprod 2004; 19:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/54\">",
"      Golombok S, Brewaeys A, Giavazzi MT, et al. The European study of assisted reproduction families: the transition to adolescence. Hum Reprod 2002; 17:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/55\">",
"      Colpin H, Soenen S. Parenting and psychosocial development of IVF children: a follow-up study. Hum Reprod 2002; 17:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/56\">",
"      Golombok S, MacCallum F, Goodman E. The \"test-tube\" generation: parent-child relationships and the psychological well-being of in vitro fertilization children at adolescence. Child Dev 2001; 72:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/57\">",
"      Place I, Englert Y. A prospective longitudinal study of the physical, psychomotor, and intellectual development of singleton children up to 5 years who were conceived by intracytoplasmic sperm injection compared with children conceived spontaneously and by in vitro fertilization. Fertil Steril 2003; 80:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/58\">",
"      Wagenaar K, van Weissenbruch MM, Knol DL, et al. Behavior and socioemotional functioning in 9-18-year-old children born after in vitro fertilization. Fertil Steril 2009; 92:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/59\">",
"      Sutcliffe AG, Taylor B, Saunders K, et al. Outcome in the second year of life after in-vitro fertilisation by intracytoplasmic sperm injection: a UK case-control study. Lancet 2001; 357:2080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/60\">",
"      Ponjaert-Kristoffersen I, Bonduelle M, Barnes J, et al. International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments. Pediatrics 2005; 115:e283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/61\">",
"      Leunens L, Celestin-Westreich S, Bonduelle M, et al. Follow-up of cognitive and motor development of 10-year-old singleton children born after ICSI compared with spontaneously conceived children. Hum Reprod 2008; 23:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/62\">",
"      Bowen JR, Gibson FL, Leslie GI, Saunders DM. Medical and developmental outcome at 1 year for children conceived by intracytoplasmic sperm injection. Lancet 1998; 351:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/63\">",
"      Leslie, GI, Cohen, J, Gibson, F, et al. Children conceived by ICSI have normal development at school age. Hum Reprod 2002; 18:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/64\">",
"      Leslie GI, Gibson FL, McMahon C, et al. Children conceived using ICSI do not have an increased risk of delayed mental development at 5 years of age. Hum Reprod 2003; 18:2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/65\">",
"      Sutcliffe AG, Saunders K, McLachlan R, et al. A retrospective case-control study of developmental and other outcomes in a cohort of Australian children conceived by intracytoplasmic sperm injection compared with a similar group in the United Kingdom. Fertil Steril 2003; 79:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/66\">",
"      Agarwal P, Loh SK, Lim SB, et al. Two-year neurodevelopmental outcome in children conceived by intracytoplasmic sperm injection: prospective cohort study. BJOG 2005; 112:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/67\">",
"      Mains L, Zimmerman M, Blaine J, et al. Achievement test performance in children conceived by IVF. Hum Reprod 2010; 25:2605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/68\">",
"      Rojas-Marcos PM, David R, Kohn B. Hormonal effects in infants conceived by assisted reproductive technology. Pediatrics 2005; 116:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/69\">",
"      Belva F, Roelants M, Painter R, et al. Pubertal development in ICSI children. Hum Reprod 2012; 27:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/70\">",
"      Lehti V, Brown AS, Gissler M, et al. Autism spectrum disorders in IVF children: a national case-control study in Finland. Hum Reprod 2013; 28:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/71\">",
"      Wen J, Jiang J, Ding C, et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril 2012; 97:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/72\">",
"      Davies MJ, Moore VM, Willson KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/73\">",
"      Shevell T, Malone FD, Vidaver J, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005; 106:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/74\">",
"      Conway DA, Patel SS, Liem J, et al. The risk of cytogenetic abnormalities in the late first trimester of pregnancies conceived through assisted reproduction. Fertil Steril 2011; 95:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/75\">",
"      Bonduelle M, Camus M, De Vos A, et al. Seven years of intracytoplasmic sperm injection and follow-up of 1987 subsequent children. Hum Reprod 1999; 14 Suppl 1:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/76\">",
"      Batcheller A, Cardozo E, Maguire M, et al. Are there subtle genome-wide epigenetic alterations in normal offspring conceived by assisted reproductive technologies? Fertil Steril 2011; 96:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/77\">",
"      Vermeiden JPW, Bernardus RE. Are imprinting disorders more prevalent after human in vitro fertilization or intracytoplasmic sperm injection? Fertil Steril 2013; 99:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/78\">",
"      Amor DJ, Halliday J. A review of known imprinting syndromes and their association with assisted reproduction technologies. Hum Reprod 2008; 23:2826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/79\">",
"      Doornbos ME, Maas SM, McDonnell J, et al. Infertility, assisted reproduction technologies and imprinting disturbances: a Dutch study. Hum Reprod 2007; 22:2476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/80\">",
"      De Rycke M, Liebaers I, Van Steirteghem A. Epigenetic risks related to assisted reproductive technologies: risk analysis and epigenetic inheritance. Hum Reprod 2002; 17:2487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/81\">",
"      Gosden R, Trasler J, Lucifero D, Faddy M. Rare congenital disorders, imprinted genes, and assisted reproductive technology. Lancet 2003; 361:1975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/82\">",
"      Bowdin S, Allen C, Kirby G, et al. A survey of assisted reproductive technology births and imprinting disorders. Hum Reprod 2007; 22:3237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/83\">",
"      Manipalviratn S, DeCherney A, Segars J. Imprinting disorders and assisted reproductive technology. Fertil Steril 2009; 91:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/84\">",
"      Bergh T, Ericson A, Hillensj&ouml; T, et al. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet 1999; 354:1579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/85\">",
"      Klip H, Burger CW, de Kraker J, et al. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod 2001; 16:2451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/86\">",
"      Lerner-Geva L, Toren A, Chetrit A, et al. The risk for cancer among children of women who underwent in vitro fertilization. Cancer 2000; 88:2845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/87\">",
"      Bruinsma F, Venn A, Lancaster P, et al. Incidence of cancer in children born after in-vitro fertilization. Hum Reprod 2000; 15:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/88\">",
"      Foix-L'H&eacute;lias L, Aerts I, Marchand L, et al. Are children born after infertility treatment at increased risk of retinoblastoma? Hum Reprod 2012; 27:2186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/89\">",
"      Moll AC, Imhof SM, Cruysberg JR, et al. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet 2003; 361:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/90\">",
"      Marees T, Dommering CJ, Imhof SM, et al. Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study. Hum Reprod 2009; 24:3220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/91\">",
"      Dommering CJ, van der Hout AH, Meijers-Heijboer H, et al. IVF and retinoblastoma revisited. Fertil Steril 2012; 97:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/92\">",
"      Lightfoot T, Bunch K, Ansell P, Murphy M. Ovulation induction, assisted conception and childhood cancer. Eur J Cancer 2005; 41:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/93\">",
"      Doyle P, Bunch KJ, Beral V, Draper GJ. Cancer incidence in children conceived with assisted reproduction technology. Lancet 1998; 352:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/94\">",
"      Raimondi S, Pedotti P, Taioli E. Meta-analysis of cancer incidence in children born after assisted reproductive technologies. Br J Cancer 2005; 93:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/95\">",
"      K&auml;ll&eacute;n B, Finnstr&ouml;m O, Lindam A, et al. Cancer risk in children and young adults conceived by in vitro fertilization. Pediatrics 2010; 126:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/96\">",
"      Romundstad LB, Romundstad PR, Sunde A, et al. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod 2006; 21:2353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/97\">",
"      Sun LM, Walker MC, Cao HL, et al. Assisted reproductive technology and placenta-mediated adverse pregnancy outcomes. Obstet Gynecol 2009; 114:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/98\">",
"      Healy DL, Breheny S, Halliday J, et al. Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia. Hum Reprod 2010; 25:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/99\">",
"      Wisborg K, Ingerslev HJ, Henriksen TB. IVF and stillbirth: a prospective follow-up study. Hum Reprod 2010; 25:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/100\">",
"      Luke B, Brown MB, Grainger DA, et al. The sex ratio of singleton offspring in assisted-conception pregnancies. Fertil Steril 2009; 92:1579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/101\">",
"      Dean JH, Chapman MG, Sullivan EA. The effect on human sex ratio at birth by assisted reproductive technology (ART) procedures--an assessment of babies born following single embryo transfers, Australia and New Zealand, 2002-2006. BJOG 2010; 117:1628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/102\">",
"      Chang HJ, Lee JR, Jee BC, et al. Impact of blastocyst transfer on offspring sex ratio and the monozygotic twinning rate: a systematic review and meta-analysis. Fertil Steril 2009; 91:2381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/103\">",
"      Scherrer U, Rimoldi SF, Rexhaj E, et al. Systemic and pulmonary vascular dysfunction in children conceived by assisted reproductive technologies. Circulation 2012; 125:1890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/104\">",
"      Carson C, Sacker A, Kelly Y, et al. Asthma in children born after infertility treatment: findings from the UK Millennium Cohort Study. Hum Reprod 2013; 28:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/105\">",
"      K&auml;ll&eacute;n B, Finnstr&ouml;m O, Nygren KG, Otterblad Olausson P. Asthma in Swedish children conceived by in vitro fertilisation. Arch Dis Child 2013; 98:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/106\">",
"      ACOG Committee on Obstetric Practice, ACOG Committee on Gynecologic Practice, ACOG Committee on Genetics. ACOG Committee Opinion #324: Perinatal risks associated with assisted reproductive technology. Obstet Gynecol 2005; 106:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/6/2154/abstract/107\">",
"      Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol 2007; 109:967.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6788 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-7BCA055868-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2154=[""].join("\n");
var outline_f2_6_2154=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREGNANCY RATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREGNANCY OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Early loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Spontaneous abortion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Proportion of singleton and multiple gestation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Monozygotic multiples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Preterm birth, LBW, and SGA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Conclusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Developmental issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Cerebral palsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Intraventricular hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Psychosocial development",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Cognitive and motor development",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Congenital anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Chromosomal and genetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Imprinting disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Obstetrical complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Perinatal mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1750985980\">",
"      Sex ratio at birth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2241569\">",
"      Other long-term issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6788\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6788|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/47/28411\" title=\"table 1\">",
"      Outcome ART v natural conceived",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=related_link\">",
"      Basic principles of genetic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24473?source=related_link\">",
"      Beckwith-Wiedemann syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/7/31865?source=related_link\">",
"      Effect of advanced age on fertility and pregnancy in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=related_link\">",
"      In vitro fertilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/15/21752?source=related_link\">",
"      Incidence, risk factors, and pathology of ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=related_link\">",
"      Intracytoplasmic sperm injection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39065?source=related_link\">",
"      Multifetal pregnancy reduction and selective termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27594?source=related_link\">",
"      Neonatal outcome, complications, and management of multiple births",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23431?source=related_link\">",
"      Preimplantation genetic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/27/43449?source=related_link\">",
"      Strategies to control the rate of high order multiple gestation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/34/12842?source=related_link\">",
"      Triplet pregnancy: Mid and late pregnancy complications and management",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_6_2155="Atypical features JIA";
var content_f2_6_2155=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Atypical features of juvenile idiopathic arthritis that should prompt consideration of leukemia*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Nocturnal pain that may cause waking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe pain, requiring opiate analgesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain out of proportion to severity of arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic symptoms out of proportion to severity of arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonarticular bone pain",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Particularly before the initiation of corticosteroid or cytotoxic therapy.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Murray, MJ, Tang, T, Ryder, C, et al. BMJ 2004; 329:959.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2155=[""].join("\n");
var outline_f2_6_2155=null;
var title_f2_6_2156="Proposed nomenclature HE";
var content_f2_6_2156=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Proposed nomeclature of hepatic encephalopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        HE type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Nomenclature",
"       </td>",
"       <td class=\"subtitle1\">",
"        Subcategory",
"       </td>",
"       <td class=\"subtitle1\">",
"        Subdivisions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A",
"       </td>",
"       <td>",
"        Encephalopathy associated with",
"        <strong>",
"         a",
"        </strong>",
"        cute liver failure",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B",
"       </td>",
"       <td>",
"        Encephalopathy associated with portal-systemic",
"        <strong>",
"         b",
"        </strong>",
"        ypass and no intrinsic hepatocellular disease",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"7\">",
"        C",
"       </td>",
"       <td colspan=\"1\" rowspan=\"7\">",
"        Encephalopathy associated with",
"        <strong>",
"         c",
"        </strong>",
"        irrhosis and portal hypertension/or systemic shunts",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Episodic HE",
"       </td>",
"       <td>",
"        Precipitated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spontaneous*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recurrent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Persistent HE",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment-dependent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minimal HE",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    For definitions, see text.",
"    <div class=\"footnotes\">",
"     * Without recognized precipitating factors.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2156=[""].join("\n");
var outline_f2_6_2156=null;
var title_f2_6_2157="Indications FNA";
var content_f2_6_2157=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F70513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F70513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sonographic and clinical features of thyroid nodules and recommendations for FNA",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Nodule sonographic or clinical features",
"      </td>",
"      <td class=\"subtitle1\">",
"       Recommended nodule threshold size for FNA",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       High-risk history*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Nodule WITH suspicious sonographic features&bull;",
"      </td>",
"      <td>",
"       <p>",
"        &gt;5 mm",
"       </p>",
"       <p>",
"        Recommendation A",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Nodule WITHOUT suspicious sonographic features&bull;",
"      </td>",
"      <td>",
"       <p>",
"        &gt;5 mm",
"       </p>",
"       <p>",
"        Recommendation I",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Abnormal cervical lymph nodes",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        All&Delta;",
"       </p>",
"       <p>",
"        Recommendation A",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Microcalcifications present in nodule",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        &ge;1 cm",
"       </p>",
"       <p>",
"        Recommendation B",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Solid nodule",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       AND hypoechoic",
"      </td>",
"      <td>",
"       <p>",
"        &gt;1 cm",
"       </p>",
"       <p>",
"        Recommendation B",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       AND iso- or hyperechoic",
"      </td>",
"      <td>",
"       <p>",
"        &ge;1-1.5 cm",
"       </p>",
"       <p>",
"        Recommendation C",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Mixed cystic-solid nodule",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       WITH any suspicious ultrasound features&bull;",
"      </td>",
"      <td>",
"       <p>",
"        &ge;1.5-2.0 cm",
"       </p>",
"       <p>",
"        Recommendation B",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       WITHOUT suspicious ultrasound features",
"      </td>",
"      <td>",
"       <p>",
"        &ge;2.0 cm",
"       </p>",
"       <p>",
"        Recommendation C",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Spongiform nodule",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        &ge;2.0 cm&loz;",
"       </p>",
"       <p>",
"        Recommendation C",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Purely cystic nodule",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        FNA not indicated&sect;",
"       </p>",
"       <p>",
"        Recommendation E",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MEN: multiple endocrine neoplasia; FMTC: familial medullary thyroid cancer.",
"     <br>",
"      * High-risk history: History of thyroid cancer in one or more first degree relatives; history of external beam radiation as a child; exposure to ionizing radiation in childhood or adolescence; prior hemithyroidectomy with discovery of thyroid cancer,",
"      <sup>",
"       18",
"      </sup>",
"      FDG avidity on PET scanning; MEN2/FMTC-associated RET protooncogene mutation, calcitonin &gt;100 pg/mL.",
"      <br>",
"       &bull; Suspicious features: microcalcifications; hypoechoic; increased nodular vascularity; infiltrative margins; taller than wide on transverse view.",
"       <br>",
"        &Delta; FNA cytology may be obtained from the abnormal lymph node in lieu of the thyroid nodule.",
"        <br>",
"         &loz; Sonographic monitoring without biopsy may be an acceptable alternative.",
"         <br>",
"          &sect; Unless indicated as therapeutic modality.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper, DS, Doherty, GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167. Copyright &copy; 2009 Mary Ann Liebert, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2157=[""].join("\n");
var outline_f2_6_2157=null;
var title_f2_6_2158="Rate of AAA repair over time";
var content_f2_6_2158=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The need for surgical repair of an abdominal aortic aneurysm increases over time",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 343px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the US ADAM trial of 1136 patients with a moderate sized abdominal aortic aneurysm, the need for surgical repair in those randomized to initial surveillance increased over time.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Lederle, FA, Wilson, SE, Johnson, GR et al, N Engl J Med 2002: 346:1437.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2158=[""].join("\n");
var outline_f2_6_2158=null;
var title_f2_6_2159="Ant scleritis inflammation";
var content_f2_6_2159=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F81029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F81029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute necrotizing anterior scleritis with inflammation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 322px; height: 215px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Acute necrotizing scleritis with inflammation in a patient with rheumatoid arthritis. Anterior bulging of the inflamed sclera is seen in association with scleral thinning due to necrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of M Reza Dana, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_6_2159=[""].join("\n");
var outline_f2_6_2159=null;
